CURRICULUM VITAE
OF
SIMON BRAMHALL MD FRCS
TABLE OF CONTENTS
PERSONAL DETAILS ............................................................................................................................ 3
APPOINTMENTS.................................................................................................................................... 4
COURSES ................................................................................................................................................ 6
MANAGEMENT ..................................................................................................................................... 8
TEACHING............................................................................................................................................ 10
RESEARCH ........................................................................................................................................... 10
Thesis Abstract ................................................................................................................................... 10
RESEARCH SUPERVISION ............................................................................................................ 11
RESEARCH GRANTS ...................................................................................................................... 11
MEMBERSHIP OF LEARNED SOCIETIES .................................................................................... 13
COMMITTEES ...................................................................................................................................... 14
OTHER ACTIVITIES ............................................................................................................................ 15
PAPERS ................................................................................................................................................. 15
CASE REPORTS ................................................................................................................................... 25
PUBLISHED ABSTRACTS .................................................................................................................. 28
BOOK CHAPTERS ............................................................................................................................... 31
PRESENTATIONS ................................................................................................................................ 36
INVITED LECTURES ........................................................................................................................... 42
CONFERENCES.................................................................................................................................... 55
REFEREES ............................................................................................................................................ 56
2
PERSONAL DETAILS
NAME
SIMON BRAMHALL
TELEPHONE
Work: 0121 371 4655
MP: 07976 278549
Email: Simon.Bramhall@uhb.nhs.uk
DATE OF BIRTH
28th October 1964
AGE
48 years
NATIONALITY
British
GMC REGISTRATION NUMBER
3358940
DEFENCE SOCIETY
Medical Protection Society
No: 160112
UNIVERSITY EDUCATION
University of Birmingham
Medical School 1983-88
PROFESSIONAL QUALIFICATIONS
MB ChB
FRCS
MD
FRCS (gen-surg)
CCST DATE
1st April 2000
PRIZES
Arthur Thompson Travelling
Scholarship
1987
MRC Rogers Fund Award
1987
Riker Elective Prize
1987
Midland Gastroenterological
Society
1993
IAP Young Investigators
Award
1994
Pancreatic Society
1995
The British Council,
Japan
1997
Foundation for Promotion
of Cancer Research
1998
CURRENT APPOINTMENT
Consultant Surgeon
The Liver Unit
Queen Elizabeth Hospital
Edgbaston
Birmingham B15 2TH
3
1988
1992
1997
1998
APPOINTMENTS
AUGUST 1988 - JANUARY 1989
HOUSE SURGEON
Mr DMA Wallace (Consultant Urologist)
Mr JWL Fielding (Consultant General Surgeon)
Queen Elizabeth Hospital
Birmingham
FEBRUARY 1989 - JULY 1989
HOUSE PHYSICIAN
Dr BT Cooper (Consultant Physician/
Gastroenterologist)
Dudley Road Hospital
Birmingham
SEPTEMBER 1989 - JANUARY 1990
TEMPORARY LECTURESHIP IN ANATOMY
School of Basic Medical Sciences
University of Birmingham
FEBRUARY 1990 - JULY 1990
SENIOR HOUSE OFFICER
Accident and Emergency Department
General Hospital
Birmingham
AUGUST 1990 -JANUARY 1991
SENIOR HOUSE OFFICER
Mr TM Milward (Consultant Plastic Surgeon)
Mr HP Henderson (Consultant Plastic Surgeon)
Leicester Royal Infirmary
Leicester
FEBRUARY 1991 - JULY 1991
SENIOR HOUSE OFFICER
Mr PS Veitch (General & Upper GI Surgery)
Mr MJ Kelly (General & Colorectal Surgery)
Leicester General Hospital
Leicester
JULY 1991 - DECEMBER 1991
PRE-FELLOWSHIP REGISTRAR
Mr DJ Campbell (General, Endocrine & GI
Surgery)
Mr JM Morrison (General & Breast Surgery)
Selly Oak Hospital
Birmingham
JANUARY 1992 - JUNE 1992
PRE-FELLOWSHIP REGISTRAR
Professor MRB Keighley (Barling Professor)
Mr D Kumar (Senior Lecturer in Surgery)
Queen Elizabeth Hospital
Birmingham
JULY 1992 - JUNE 1993
SENIOR HOUSE OFFICER
Mr MD Middleton (Gen & Vasc Surgery)
Mr MD Goldman (Gen & Vasc Surgery)
East Birmingham Hospital
Birmingham
JUNE 1993 - MAR 1995
CLINICAL RESEARCH FELLOW
University Department of Surgery
City Hospital NHS Trust
Dudley Road
Birmingham B18 7QH
4
APPOINTMENTS (cont.)
APRIL 1995 - SEPT 1995
CLINICAL LECTURER IN SURGERY
Mr RA Cobb (Gen & Colorectal Surgery)
Mr HJ Thomson (Gen, UGI & HPB Surgery)
Birmingham Heartlands Hospital
Bordesley Green East
Birmingham B9 5SS
OCT 1995 - SEPT 1996
CLINICAL LECTURER IN SURGERY
Mr JWL Fielding (Gen, Breast & UGI Surgery)
Mr MT Hallissey (Gen, Breast & UGI Surgery)
Professor J Temple (Gen & UGI Surgery)
Mr D England (Gen & Breast Surgery)
Queen Elizabeth Hospital
Birmingham B15 2TH
OCT 1996 - SEPT 1997
CLINICAL LECTURER IN SURGERY
Professor P McMaster
Mr J Buckels
Mr D Mayer
(HPB & Liver Transplant Surgery)
Queen Elizabeth Hospital
Birmingham B15 2TH
OCT 1997 - JAN 1998
CLINICAL LECTURER IN SURGERY
Mr D Ellis (Gen & UGI Surgery)
Mr D Gourevitch (Gen & UGI Surgery)
Mr K Wheatley (Gen & Colorectal Surgery)
Sandwell District General Hospital
Sandwell
West Midlands
FEB 1998 - MAR 1998
VISITING LECTURER IN SURGERY
Professor T Sano (Gastric Cancer Division)
National Cancer Center Hospital
Tokyo
Japan
APR 1998 – SEPT 1998
CLINICAL LECTURER IN SURGERY
Mr D Ellis (Gen & UGI Surgery)
Mr D Gourevitch (Gen & UGI Surgery)
Mr K Wheatley (Gen & Colorectal Surgery)
Sandwell District General Hospital
Sandwell
West Midlands
OCT 1998 – SEPT 1999
CLINICAL LECTURER IN SURGERY
Professor MRB Keighley (Barling Professor)
Mr D Morton (Senior Lecturer - Coloproctology)
Mr S Radley (Senior Lecturer - Coloproctology)
Queen Elizabeth Hospital
Birmingham B15 2TH
5
APPOINTMENTS (cont.)
OCT 1999 – SEPT 2001
CLINICAL LECTURER IN SURGERY
Professor P McMaster
Mr J Buckels
Mr D Mayer
Mr D Mirza
Mr D Candinas
(HPB & Liver Transplant Surgery)
Queen Elizabeth Hospital
Birmingham B15 2TH
OCT 2001 – JAN 2002
CLINICAL LECTURER IN SURGERY
Queen Elizabeth Hospital
Birmingham B15 2TH
FEB 2002 – AUG 2002
HONORARY CONSULTANT SURGEON
Clinical Lecturer in Surgery
The Liver Unit
Queen Elizabeth Hospital
Birmingham B15 2TH
AUG 2002 - CURRENTLY
CONSULTANT SURGEON
The Liver Unit
Queen Elizabeth Hospital
Birmingham B15 2TH
COURSES
1. Small and Large Bowel Anastomosis Techniques
Department of Surgery, University of Leicester.
24.11.90 and 1.12.90
2. 36th Intensive Course in Surgery
Dudley Road Hospital, Birmingham.
9.3.92 to 20.3.92
3. Molecular Biology for Clinicians
Department of Molecular Biology, Warwick University.
13.12.93 to 16.12.93
4. Lecturing and Presentation Skills
Staff Development Unit, University of Birmingham.
13.11.95 and 14.11.95
5. Personal Tutoring
Staff Development Unit, University of Birmingham.
12.01.96
6. Writing a Successful Research Proposal
Staff Development Unit, University of Birmingham.
27.03.96 and 22.05.96
7. Writing for Publication
Staff Development Unit, University of Birmingham.
18.04.96
8. Teaching in a Clinical Setting
Staff Development Unit, University of Birmingham.
24.06.96
6
9. Strategies for Assessment
Staff Development Unit, University of Birmingham.
25.11.96
10.Supervising Students
Staff Development Unit, University of Birmingham.
25.03.97
11.Course Design
Staff Development Unit, University of Birmingham.
15.05.97
12.Management Awareness
Department of Human Resource Management and Industrial Relations, University of Keele.
27.04.98 – 28.04.98
13.2nd Scottish Therapeutic Endoscopy Workshop
Glasgow Royal Infirmary.
08.10.98 – 10.10.98
14.Recruitment and Selection Briefing
Staff Development Unit, University of Birmingham.
15.10.98
15.Training the Trainers
Royal College of Surgeons of England, London.
19.01.00 – 20.01.00
16.Preparing for the Consultants Interview
First Course, Birmingham
29.04.00
17.2nd International Split Liver Course
University of Hamburg
04.10.01 – 05.10.01
18.Paris Right Liver Lobe Course: From Resection to Donation
Clichy Hospital, Paris
14.12.01 – 15.12.01
19. UHB Leadership Programme
Birmingham
03/08-09/08
20. Laparoscopic HPB Surgery
Surgical Skills Centre, Dundee
28/05/08
21. Chairing Meetings Effectively
UHB Consultant Development Programme
08/07/08
22. MedicoLegal Course
Lyons Davidsons Solicitors, Leeds
18/6/09
23. Teaching the Teachers
UHB
16/09/13
7
MANAGEMENT
I am or have been directly responsible for the following members of University or NHS staff:
Dr Darren Williams, PhD Student
Dr Paul Wilson, Clinical Research Fellow
Mr Martin Wadley, Clinical Research Fellow
Mr John Whiting, Clinical Research Fellow
Mr Mangta Manu, Clinical Research Fellow
Mr Roger Brammer, Clinical Research Fellow
Mr Anant Desai, Clinical Research Fellow
Ms Sarah Barclay, Research Nurse
Ms Patricia Donoghue, Research Nurse
Mr Michael O’Keefe, Research Nurse
Ms Josephine Lee, Research Nurse
Mr Eoin Scott, Research Nurse
Ms Catherine Markham, Research Nurse
Ms Helen Hewitt, Research Nurse
Mr Abraham John, Trust Grade/Research Fellow
Mr Edward Alababra, Trust Grade/Research Fellow
Mr Chandra Bhatti, Trust Grade/Research Fellow
Mr Anand Bhatt, Trust Grade/Research Fellow
Mr Ricky Bhogal, Trust Grade/Research Fellow
Mr David Bartlett, Trust Grade/Research Fellow
Mr Rupesh Sutaria, Trust Grade/Research Fellow
Mr Timothy Evans, Trust Grade/Research Fellow
Mr Barney Stephenson, Trust Grade/Research Fellow
Mr Gregory Moorlock, PhD Student
Mr Richard Wilkin, Trust Grade/Research Fellow
Mr Richard Laing, Trust Grade/Research Fellow
I was responsible for negotiating the financial contracts for the majority of these posts with the post
sponsors, I formulated the posts and wrote the job descriptions and was responsible for short-listing
and interviewing all of the candidates. Following their appointment I have become their in-line
manager and clinical project supervisor, in the majority of cases I am also their academic supervisor.
I have maintained a strong academic record as a consultant:
 Development and funding for 3 substantive Trust Grade Research Fellows
o These posts now form an integral part of our unit staffing at weekends and during the
week they are based in laboratories carry out basic science research.
o In the early stages I helped supervise their research degrees but more recently this has
been carried out by Prof D Adams and Dr P Newsome and I provide clinical
mentorship.
o 4 of these candidates have gone on to obtain MRC Training fellowships.
 Since 1995 I have supervised 6 students studying for an MD and all bar one have been
awarded, in addition I have also supervised 2 students who have been awarded PhDs.
 I have also supervised 7 research nurses (plus 4 NCRN research nurse posts) all who have
been involved in carrying out clinical trials on my behalf
 I am both an internal and an external examiner for MD theses.
 Since 1993 I have been involved in raising more than £2.5 million of research grants.
o Recently: funding from AHRC for a PhD into the ethical study of directed donation.
o As a collaborator in the CRCUK funded ESPAC 4 prospective tissue collection.
 Active recruitment into clinical trials; major recruiter into ESPAC3, BilCap, GemCap, Silver
study
 2002-2003: data safety monitoring committee for PRT 030 & 031 trials.
 2000-2001: Trial steering committee for Aphton PC3 trial.
 2002: Clinical advisor to Bristol Myers Sqibb.
 2009-current: Member of UHB Charities Grant Committee.
 Current journal reviewer for: British Journal of Surgery, Digestive Surgery, Transplantation,
Liver Transplantation, American Journal of Transplantation, World Journal of Surgical
Oncology.
8
o

o
o
o
o
Previous reviewer for Lancet, Nature Reviews Cancer, British Journal of Cancer,
GUT, Expert Opinion on Investigational Drugs and the International Journal of
Cancer.
2009-current: member of editorial Board of World Journal of Gastrointestinal Surgery.
Editorial Board International Journal of Hepatology
Editorial Board World Journal of Methodology
CRUK Stratified Medicine Programme – Board of Human Tissue Repository
MRC grant peer review process
Since becoming a consultant I have been actively involved in Trust management:
 2006-2008: clinical representative on modernising patient administration working group.
 2006- 2009: liver surgical representative on Hospital @ Night working group.
 Development of junior doctor deal and EWTD compliant rotas for liver unit doctors.
o Employment of new staff.
o Development of Research Fellow grade.
 2002-2009: Clinical lead for organ procurement, oversaw merger of Birmingham with
Coventry teams, further increase in coordinators and finally the transfer of all services to
NHSBT.
 Business cases for NHBD, LRLT and Laparoscopic HPB surgery as above.
 2002-2008: Clinical lead for NCRN within Trust. Management of 4 NCRN funded research
nurses.
 2005-2008: Clinical Lead for Choose and Book.
 2005-2006: Surgical representative on Theatre A* equipment committee for the new hospital
development.
 2005-2006: Member of UK Transplant working group investigating zonal liver allocation.
 2005-2006: National peer reviewer for National Cancer Peer Review Programme.
 2007-2010: member of BTS Council.
 2005-2006: BTS higher awards committee.
 2006-2009: member of council for Pancreatic Society of GB and Ireland.
 2006: Author of a damming report into organs lost to transplantation. I wrote the report and
circulated copies to Intensive Care Society, BMA, ASGBI, all political parties and to the DH.
After several meetings with the DH, Rosie Winterton (then minister with responsibility for
transplantation) agreed to the setting up of the Organ Donation Task Force.
 2006-current: Transplant surgical representative on the DH ODTF. Successful completion of 2
reports into aspects of organ donation.
 2008-current: Laboratory Automation Committee, as part of the move to the new hospital.
 2009-current: UHB Organ Donation Committee, set up in response to the report from ODTF.
 2008-current: elected representative on the Trust Clinical Excellence Awards Committee.
 2008-2009: New Hospital Bed Allocation Committee.
 2008-current: member of novel therapeutics committee.
 2007-2009: Trust appointed Associate Divisional Director for length of stay, discharge and
theatres.
o Development of a strategy for Trust wide pre-admission services.
o Development of strategy to deliver admission on day of surgery
o Development of electronic notification of expected length of stay.
o Development of strategy for Trust wide Discharge team to deal with long stay
patients.
 Leading the Best in Care - Leadership course
 RCS invited review mechanisms
 UHB Clinical Governance case review of individual performance
 UHB representative on NHSBT LAG
 2010-2013 BTS Councillor without Portfolio
 RCS Board of Assessors
 NPSA Safety Alert Task & Finish Group
9
TEACHING
As a temporary lecturer in anatomy I taught medical and dental undergraduates, in both a formal
classroom setting and individually in the dissecting room. I also examined undergraduate medical and
dental students for their first MB, or equivalent, in topographical anatomy and histology. This involved
both marking written material and anatomy viva-voce examinations.
I have supervised medical students undertaking their Public Health and Epidemiology projects the data
contained within them has been presented at the West Midlands Surgical Society and Midlands
Gastroenterolgical Society meetings.
I have taught medical undergraduates in clinical subjects, at the patients’ bedside, in practical
techniques and in more formal tutorials. I have been actively involved in the third year surgical
students formal lecture programme; I have lectured to the 4th year dental students and 1st year medical
students on anatomy. Ever since obtaining my FRCS I have been involved in formal and informal
teaching and mock clinical examinations for fellowship candidates and more recently for students
sitting their FRCS(gen surg).
I have designed and taught a special study module on pancreatic cancer to 3rd year medical students.
This involves 30 hours of clinical teaching to a small group of students on a specific topic. The students
are shown the interrelationship between basic science and clinical management of pancreatic cancer;
present a clinical case and each produce a dissertation.
I was a lead tutor in the digestive disease module to the pre-clinical undergraduate students and
designed and produced part of this course. This involved four hours of tutorial-based teaching.
I am a University internal examiner for higher degrees and have been involved as an examiner for the
MBChB and BDS.
I have also been involved in the following:
 2002-2008: UHB clinical lead for 5th year surgery.
 Educational Supervisor for one FY1 and one specialist trainee each year.
 2005: Development of Liver Unit as a Postgraduate Training Institution recognised by the
GMC for overseas graduates to obtain GMC registration.
 Bedside/clinical teaching of 3rd, 4th and 5th year medical students.
 Liver unit clinical lead for work experience students.
 Lecture based teaching to 3rd medical students, regional trainees, foundation year doctors and
professions allied to medicine.
 National lectures on organ donation, liver transplantation and HPB surgery.
 2005-2007: elected member of the British Transplantation Society Education and Training
Committee.
 2007-2010: Chairman of the BTS Training and Education Committee.
 2007-2010: BTS representative on the ASGBI Education Training Board.
o Member of NHSBT education group to develop syllabus for delivery of education around
organ donation
o Development with others of MSC in Organ Donation
o RCS MRCS e-learning package
o University of Birmingham representative on WM Deanery School of Surgery
RESEARCH
Thesis Abstract
Proteolytic degradation of the extracellular matrix (ECM) is an essential component of tumour spread.
The matrix metalloproteinases (MMPs) are capable of degrading different substrates within the ECM.
The MMPs belong to a family of proteolytic, zinc-binding enzymes involved in several physiological
processes such as angiogenesis and morphogenesis. The functional activity of the activated forms of
the MMPs is controlled by specific tissue inhibitors of the metalloproteinases (TIMPs). Prior to my
publications in this area very little was known of the role of MMPs and TIMPs in pancreatic cancer.
10
The aim of my thesis was to characterise the expression of several of the key MMPs and their specific
TIMPs. Expression was determined in human pancreatic cancers, chronic pancreatitis and healthy
pancreas using immunohistochemistry and Northern analysis. The expression of the MMPs and TIMPs
was compared with clinical and histopathological features of the disease known to affect prognosis.
The cell types involved in expression of the enzymes were determined by in-situ hybridisation. Several
human pancreatic cancer cell lines were characterised for MMP and TIMP expression and a number of
MMP inhibitors were tested for their ability to inhibit invasion of the basement membrane in an invitro model.
RESEARCH SUPERVISION
1.PhD Student, October 1995-September 1998. Mr D Williams.
The regulation of activation and expression of MMPs and TIMPs by hypoxia and
VEGF in pancreatic cancer.
Awarded 2000
2. MD Student, April 1997-Mar 1999. Mr M Wadley.
Circulating tumour cell release and expression and activation of MMPs in patients
with primary breast cancer.
Awarded 2001
3. MD Student, June 1997-May 1999. Mr J Whiting.
The relationship between the MMPs and apoptosis in gastric cancer and premalignant gastric lesions.
Awarded 2004
4. MD Student, February 1998-February 2000. Mr M Manu.
The influence of neural factors on perineural invasion in pancreatic cancer.
5. MD Student, August 2000-May 2002. Mr Roger Brammer.
The role of anti-angiogenic factors in acute pancreatitis.
Awarded 2003
6. MD Student, March 2001-September 2003. Mr Anant Desai.
The role of anti-angiogenic factors in gastro-oesophageal cancer.
Awarded 2008
7. MD Student, November 2003 – July 2008. Mr A John.
Endostatin Regulation in HPB Malignancy.
Awarded 2009
8. PhD Student, October 2003 - 2005. Mr E Alababra.
Macrophage Induction in Chronic Liver Rejection.
Awarded 2009
9. PhD Student, October 2009 – September 2012. Mr Gregory Moorlock.
Conditional Organ Donation.
Awarded 2013
RESEARCH GRANTS & OTHER FUNDING
1. Royal College of Surgeons of Edinburgh, Research Committee.
The Expression of Metalloproteinases and Tissue Inhibitors of Metalloproteinases
in Human Pancreatic Cancer.
SR Bramhall 1993 £2,800.
2. Dudley Road Hospital Research Committee.
The Expression of Metalloproteinases and Tissue Inhibitors of Metalloproteinases
in Human Pancreatic Cancer.
SR Bramhall, JP Neoptolemos 1994 £2,780.
11
3. Faculty of Medicine and Dentistry Research Grant.
Joint Department of Surgery Application. M Crundwell, SR Bramhall, SMA
Phillips, D Morton, NK Green, JP Neoptolemos 1994 £3,000.
4. Duphar Laboratories Ltd.
Clinical Trial Comparing the Effects of Creon 8000 with Creon 25000 in Patients
who have Undergone Pancreatectomy.
SR Bramhall, JP Neoptolemos 1994 £16,000.
5. Birmingham Heartlands Hospital Research Committee.
The Control of Metalloproteinase Induced Invasion and Metastases in Human
Pancreatic Cancer.
SR Bramhall 1995 £2000
6. British Biotech Pharmaceuticals Ltd.
Phase II Clinical Trial of BB2516 in Patients with Advanced Pancreatic Cancer.
JD Evans, SR Bramhall, JP Neoptolemos. 1996 £52,000.
7. British Biotech Pharmaceuticals Ltd.
Phase II Clinical Trial of BB2516 in Patients with Advanced Pancreatic Cancer.
SR Bramhall. 1997 £11,000.
8. Faculty of Medicine and Dentistry Research Grant.
The Control of Metalloproteinase Induced Invasion and Metastasis in Human
Pancreatic and Colorectal Cancer.
SR Bramhall, D Williams, JP Neoptolemos. 1995 £1403
9. The Royal College of Surgeons of England Surgical Research Fellowship.
Regulation of Cell Proliferation and Apoptosis in Pancreatic Cancer.
JD Evans, SR Bramhall, M Eggo. 1996 £30,000
10.British Biotech Pharmaceuticals Ltd.
A Pivotal Randomised Controlled Study Comparing Marimastat Against
Gemcitabine as First Line Therapy in Patients with Non-resectable Pancreatic
Cancer.
SR Bramhall, J Buckels. 1997 £74,000.
11.British Biotech Pharmaceuticals Ltd.
Phase III Clinical Trial of Lexipafant in Severe Acute Pancreatitis.
P Wilson, SR Bramhall, D Adams. 1998 £50,000.
12.British Biotech Pharmaceuticals Ltd.
Phase III Clinical Trial of Marimastat in Advanced Gastric Cancer.
SR Bramhall, MT Hallissey, JWL Fielding. 1998 £128,000.
13.British Biotech Pharmaceuticals Ltd.
A Double-Blind, Placebo-Controlled, Randomised Study Comparing Gemcitabine
+ Marimastat vs. Gemcitabine + Placebo as First Line Therapy in Patients with
Locally Advanced or Metastatic Pancreatic Cancer.
SR Bramhall, JAC Buckels. 1998 £72,000.
14.The Royal College of Surgeons of England Research Fellowship.
Apoptosis causes increased expression of matrix metalloproteinases.
JL Whiting, Mr JWL Fielding, SR Bramhall. 1998 £39,000.
12
15.British Biotech Pharmaceuticals Ltd.
A Double-Blind, Placebo-Controlled, Minimized Phase III Study Comparing
Marimastat to Placebo as Adjuvant Therapy in Patients with Resectable Pancreatic
Cancer.
SR Bramhall, JAC Buckels. 1998 £50,000.
16.Eli Lilly and Company Ltd. Educational Grant.
A Randomised Phase II Trial of Neoadjuvant Therapy for Patients with Resectable
Pancreatic Cancer; Gemcitabine alone versus Gemcitabine Combined with
Cisplatin versus Gemcitabine Combined with Radiotherapy.
SR Bramhall, D Kerr, J Buckels, D Spooner. 1999 £180,000.
17.The Liver Foundation, Birmingham Liver Unit.
Two year funding for a Hepato-Pancreato-Biliary Research Nurse.
SR Bramhall, JAC Buckels, S Ingelby. 1999 £55,000.
18.The Eveson Charitable Trust.
A Randomised Phase II Trial of Neoadjuvant Therapy for Patients with Resectable
Pancreatic Cancer; Gemcitabine alone versus Gemcitabine Combined with
Cisplatin versus Gemcitabine Combined with Radiotherapy.
SR Bramhall. 1999 £75,000.
19.The Wellcome Trust, Clinical Research Fellowship.
Anti-angiogenic factors in acute pancreatitis.
R Brammer, S Bramhall, M Eggo. 2000 £46,000.
20.The Hilda Avery Research Trust.
Anti-angiogenic factors in gastro-oesophageal cancer.
A Desai, JWL Fielding, SR Bramhall. 2001 £120,000.
21.Aphton Corporation.
A randomised, parallel group, active comparator controlled, multi-centre study to
evaluate the efficiacy and safety of G17DT in subjects with advanced pancreatic cancer.
SR Bramhall, JAC Buckels. 2001 £35,000.
22.Aphton Corporation.
Prospective, randomised, controlled, double-blind, multi-national, multi-center study of
G17DT immunogen in combination with gemcitabine versus placebo in combination with
gemcitabine in previously untreated subjects with locally advanced (nonresectable stage
II and III), recurrent disease following primary resection, or metastatic (stage IV)
adenocarcinoma of the pancreas.
SR Bramhall, JAC Buckels. 2002 £40,000.
23. UK Transplant.
Non Heart Beating Organ Donation.
SR Bramhall, Organ Procurement Team, Ms J Dutton. 2004 £150,000 + £110,000 recurring.
24. Fujisawa
Clinical Nurse Specialist in Post Transplant Diabetes.
SR Bramhall. 2005 £61,200.
25. Arts & Humanities Research Council.
An empirically informed ethical analysis of directed and conditional cadaveric organ donation.
H Draper, SR Bramhall. 2009 £65,940
26. Cancer Research UK
European Study Group for Pancreatic Cancer Trial 4 prospective sample collection - ESPAC 4T
Collaborator. 2009 £390,985.70
13
27. NHS Blood and Transplant
National Organ Retrieval Service
SR Bramhall, Division 2 Management. 2010 £1.95million
28. Cancer Research UK
Stratified Medicine Programme
Birmingham Biosample Collaborative Hub SR Bramhall (Collaborator). 2011 £298,330
MEMBERSHIP OF LEARNED SOCIETIES
1. Pancreatic Society of Great Britain and Ireland.
2. European Pancreatic Club.
3. Surgical Research Society.
4. West Midlands Surgical Society.
5. European Digestive Surgery.
6. Midland Gastroenterological Society.
7. Association of Surgeons of Great Britain and Ireland.
8. Association of Upper GI Surgeons.
9. International Association of Pancreatology.
10. British Transplantation Society.
11. International Liver Transplant Society.
COMMITTEES
1. Surgical Training Sub-Committee.
Academic Representative, 1997 – 2001.
2. Upper GI Site Specific Sub-group of the Cancer Services Clinical Advisory
Group.
HPB surgical representative, 1998 – 2001.
3. National Database Sub-Committee, Pancreatic Society of Great Britain and
Ireland.
1997 – 1998.
4. West Midlands Region Third Part FRCS Working Party.
1998 – 1999.
5. West Midlands Infection Specialist Advisory Group.
1995 – 2001.
6. Data Safety Monitoring Committee PRT 030 & 031 Trials
Daiichi Pharma 2002-2003.
7. Pan Birmingham NCRN
Clinical Lead UHB NHS Trust, 2002- current.
8. University Hospital NHS Trust
Clinical Lead for 5th Year Surgery, 2002-current.
9. British Transplantation Society
Training Committee, 2005-current.
10. UK Transplant
Working Group to Review Liver Zones and Liver Allocation, 2005-2007.
11. University Hospital NHS Trust
Theatre A* Equipment for New Hospital project, 2005-2007.
12. Pancreatic Society of GB and Ireland
Committee, 2005-2009.
14
13. University Hospital NHS Trust
The Modernising Patient Administration Steering Group, 2005-2008.
14. Department of Health
Donor Task Force. 2006-current.
15. University Hospital Birmingham NHS Foundation Trust
Hospital 24/7. 2006-2009.
16. British Transplantation Society
Council
2007-2013.
17. University Hospital Birmingham NHS Foundation Trust
Organ Donation Committee. 2009-current.
18. University Hospital Birmingham Charities Grant Committee
2009-current.
19. Editorial Board World Journal of Gastrointestinal Surgery
2009-current.
20. Editorial Board International Journal of Hepatology
2010-current
OTHER ACTIVITIES
I was chairman of my schools Young Enterprise Company in 1981/2 that won the Midlands Regional
Young Enterprise competition and came 6th nationally. On a personal level, prizes were won in the
Young Enterprise commerce examination; first place in the Midlands, and in the top ten nationally.
From 1972 to 1983 I had a continuous interest in scouting through cubs to venture scouts and then to
scout leader with a local group, winning the venture scout award.
My fourth year elective period was spent in Africa. I lived for 2 months at Uzuakoli leprosy settlement,
Imo State, Nigeria, working with chronically disabled patients. During this period I surveyed the
disabilities of the 199 long-term residents at the settlement, documenting the neurological damage
caused by their disease.
I have two children and most of my spare time is taken up with family orientated activities.
I have also reviewed manuscripts for the Lancet, Nature Reviews Cancer, British Journal of Cancer,
GUT, British Journal of Surgery, Transplantation, Digestive Surgery, Expert Opinion on
Investigational Drugs and the International Journal of Cancer. I have been involved in reviewing and
editing the pancreatic cancer page of the CancerHelp UK web site and patient information matrial for
The British Liver Trust. I have also reviewed grant applications for the Royal College of Surgeons of
England Fellowship programme.
I have worked with Bristol Myers Sqibb and Daiichi as an advisor on clinical trials in pancreatic cancer
and sat on the steering committee for the Aphton sponsored PC3 trial. I was the only European
representative on a Data Safety Monitoring Board for a Daiichi clinical trial in pancreatic cancer.
PAPERS
1. Bramhall SR, Veitch PS, Gourevitch D, Wicks AC.
An improved method for oesophageal intubation.
Annals of the Royal College of Surgeons of England 1993;75:189-92.
15
2. Stonelake PS, Powell J, Dunn JA, Warwick J, Bramhall SR, Neoptolemos JP, Baker PR,
Morrison JM.
Influence of timing of surgery during menstrual cycle on survival of premenopausal women with
operable breast cancer.
The Breast 1995;4:19-24.
3. Bramhall SR, Neoptolemos JP.
Mini-symposium: pancreatic cancer. Adjuvant therapy.
Current Practice in Surgery 1994;6(3):161-166.
4. Bramhall SR, Allum WH, Jones AG, Allwood A, Cummins C, Neoptolemos JP.
Incidence, treatment and survival in 13,560 patients with pancreatic cancer: An epidemiological
study in the West Midlands.
British Journal of Surgery 1995;82(1):111-115.
5. Bramhall SR, Neoptolemos JP.
The role of adjuvant chemo- and radiotherapy in pancreatic cancer.
Digestive Surgery 1994;11:408-413.
6. Bramhall SR, Crundwell MC, Durr C, Goldman MD.
The evolution of a laparoscopic cholecystectomy service in a district general hospital.
Journal of the Royal College of Surgeons of Edinburgh 1996;41(3):155-159.
7. Williams JG, Bramhall SR, Neoptolemos JP.
Purse-string pancreaticojejunostomy following pancreatic resection.
Digestive Surgery 1997;14:183-186.
8. Bramhall SR, Stamp GWH, Dunn J, Lemoine NR, Neoptolemos JP.
Expression of collagenase (MMP2), stromelysin (MMP3) and tissue inhibitor of the
metalloproteinases (TIMP1) in pancreatic and ampullary disease.
British Journal of Cancer 1996;73:972-978.
9. Bramhall SR, Neoptolemos JP.
Advances in the diagnosis and treatment of pancreatic cancer.
Gastroenterologist 1995;3(4):301-310.
10.Bramhall SR, Neoptolemos JP, Stamp GWH, Lemoine NR.
Imbalance of expression of matrix metalloproteinases (MMPs) and tissue inhibitors of the matrix
metalloproteinases (TIMPs) in human pancreatic carcinoma.
Journal of Pathology 1997;182:347-355.
11.Bramhall SR, Neoptolemos JP.
Adjuvant chemotherapy in pancreatic cancer.
International Journal of Pancreatology 1997;21(1):59-63.
12.Evans JD, Wilson PG, Carver C, Bramhall SR, Buckels JAC, Mayer AD, McMaster P,
Neoptolemos JP.
Outcome of surgery for chronic pancreatitis.
British Journal of Surgery 1997;84(5):624-629.
13.Neoptolemos JP, Russell RCG, Bramhall SR, Theis B. For the UK Pancreatic Cancer Group
(UKPACA).
Low mortality following resection for pancreatic and periampullary tumours in 1026 patients: UK
survey of pancreatic specialist units.
British Journal of Surgery 1997;84(10):1370-1376.
16
14.Bramhall SR.
The matrix metalloproteinases and their inhibitors in pancreatic cancer: from molecular science to
a clinical application.
International Journal of Pancreatology 1997;21(1):1-12.
15.Evans JD, Eggo MC, Donovan IA, Bramhall SR, Neoptolemos JP.
Serum levels of insulin-like growth factors (IGF-I and IGF-II) and their binding protein
(IGFBP-3) are not elevated in pancreatic cancer.
International Journal of Pancreatology 1997;22(5):95-100.
16.Bramhall SR.
The use of molecular technology in the differentiation of pancreatic cancer and chronic
pancreatitis.
International Journal of Pancreatology 1998;23:83-100.
17.Neoptolemos JP, Ghaneh P, Andrén-Sandberg A, Bramhall SR, Patankar R, Kleibeuker JH,
Johnson CD.
Treatment of pancreatic exocrine insufficiency after pancreatic resections: Results of a
randomised, double-blind, placebo-controlled, cross-over study of high versus standard dose
pancreatin.
International Journal of Pancreatology 1999;25(3):171-180.
18.Bramhall SR, Harrison JD, Burton A, Wallace DMA, Chan KK, Fielding JWL.
A phase II trial of radical surgery for locally advanced pelvic neoplasia.
British Journal of Surgery 1999;86(6):805-812.
19.Bramhall SR.
Stromal degradation by the malignant epithelium in pancreatic and ampullary cancer and the
therapeutic potential of proteolytic inhibition.
Journal of Hepato-Biliary-Pancreatic Surgery 1998;5(4):392-401.
20.Bramhall SR.
Advances in the treatment of pancreatic cancer.
Aesculapius 1998;18:21-23.
21.Manu M, Buckels JAC, Bramhall SR.
Management of pancreatic cancer at the turn of the century.
Update 1999 4th March:442-448.
22.Bramhall SR.
Academic higher surgical training after the Calman reforms.
Surgery 1999;17(7):Scalpel 2.
23.Brammer R, Buckels JAC, Bramhall SR.
Advances in non-operative therapy in pancreatic cancer.
International Journal of Clinical Practice 2000;54(6):373-381.
24.Manu M, Buckels J, Bramhall SR.
Molecular technology and pancreatic cancer.
British Journal of Surgery 2000;87:840-853.
25.Garcia CE, Bramhall S, Mirza DF.
Use of Marginal Donors.
Current Opinion in Organ Transplantation 2000;5:50-56.
26.Bramhall SR.
Novel non-operative treatment and treatment strategies in pancreatic cancer.
Expert Opinion on Investigational Drugs 2000;9(6):1179-1195.
17
27.Satoi S,Bramhall SR, Solomon M, Mayer AD, Ville de Goyet J, Buckels JAC, McMaster P,
Mirza DF.
The use of liver grafts from donors with bacterial meningitis.
Transplantation 2001;72(6):1108-1113.
28.Bramhall SR, Rosemurgy A, Buckels JAC, On behalf of Marimastat Pancreatic Cancer Study
Group.
Marimastat as first line therapy for patients with unresectable pancreatic caner – A randomized
trial.
Journal of Clinical Oncology 2001;19(15):3447-3455.
29.Ferry DR, Deakin M, Baddeley J, Daryanani S, Bramhall S, Anderson DA, Wakelam MJO,
Doran J, Pemberton G, Young AM, Buckels J, Kerr DJ.
A phase II study of the 5-lipoxygenase inhibitor, CV6504, in advanced pancreatic cancer:
Correlation of clinical data with pharmacokinetic and pharmacodynamic endpoints.
Annals of Oncology 2000;11:1165-1170.
30.Bramhall SR, Minford E, Gunson B, Buckels JAC.
Liver transplantation in the UK.
World Journal of Gastroenterology 2001;7(5):602-611.
31.Bramhall SR, Hallissey MT, Whiting J, Scolefield J, Tierney G, Stuart R, Hawkins R, McCulloch
P, Maughan T, Brown PD, Baillet M, Fielding JWL.On behalf of Marimastat Gastric Cancer
Study Group.
Marimastat as maintenance therapy for patients with advanced gastric cancer: A randomized trial.
British Journal of Cancer 2002;86(12):1864-70.
32.Bramhall SR, Schulz J, Neumatis J, Brown PD, Baillet M, Buckels JAC On behalf of Marimastat
Pancreatic Cancer Study Group.
A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat
with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer
British Journal of Cancer 2002;87(2):161-7.
33.Bramhall SR, Gur U, Coldham C, Gunson BK, Mayer AD, McMaster P, Candinas D, Buckels
JAC, Mirza DF.
Liver resection for colorectal metastases.
Annals of the Royal College of Surgeons of England 2003;85;334-339.
34.Brammer R, Bramhall SR, Mirza DF, Mayer AD, McMaster P, Buckels JAC.
Complex liver trauma: A ten-year experience.
British Journal of Surgery 2002;89(12):1532-1537.
35.Teixeira P, Wilde J, Bramhall SR, Gunson B, Mutimer D, Buckels J, McMaster P, Mirza DF.
Liver transplantation in haemophilia.
British Journal of Haematology 2002;117(4):952-956.
36.Leelaudomlipi S, Bramhall SR, Gunson BK, Candinas D, Buckels JAC, McMaster P,
Mirza DF, Mayer AD.
Hepatic artery aneurysm in adult liver transplantation.
Transplant International 2002;16(4):257-261.
37. Markham C, Stocken DD, Hassan AB. (Bramhall S)
Benefit versus toxicity in advanced pancreatic cancer: report of a phase II irinotecan-cisplatin
combination.
British Journal of Cancer 2003;89(10):1860-1864.
38. Soonawalla Z, Bramhall S.
The potential clinical role of matrix metalloproteinases.
Chinese Journal of Practical Surgery 2003;23(10):635-637.
18
39. Jarufe NP, Coldham C, Mayer AD, Mirza DF, Buckels JAC, Bramhall SR.
Favourable prognostic factors in a large UK experience of the head of the pancreas and
periampullary region.
Digestive Surgery 2004;21:202-209.
40. Soonawalla ZF, Orug T, Badminton MN, Elder GH, Rhodes JM, Bramhall SR, Elias E.
Liver transplantation as a cure for acute intermittent porphyria.
Lancet 2004;363(9410):705.
41. Tekin K, Imber, C J, Atli M, Gunson BK, Bramhall SR, Mayer D, Buckels JA, McMaster P,
Mirza DF.
A simple scoring system to evaluate the effects of cold ischemia on marginal liver donors.
Transplantation 2004;77(3):411-416.
42. Muralidharan V, Imber C, Leelaudomlipi S, Gunson BK, Buckels JAC, Mirza DF, Mayer AD,
Bramhall SR.
Arterial conduits for hepatic artery revascularisation in adult liver transplantation.
Transplant International 2004;17:163-168.
43. Silva MA, Mirza DF, Bramhall SR, Mayer AD, McMaster P, Buckels JAC.
Treatment of hydatid disease of the liver. Evaluation of a UK experience.
Digestive Surgery 2004;21:227-234.
44. Clift PF, Townend JN, Bramhall S, Isaac JN.
Successful treatment of severe portopulmonary hypertension after liver transplantation by bosentan.
Transplantation 2004;77(11):1774-1775.
45. Brammer RD, Bramhall SR, Eggo MC.
Endostatin expression in pancreatic tissue is modulated by elastase.
British Journal of Cancer 2005;92:89-93.
46. Jarufe N, McMaster P, Mayer AD, Mirza DF, Buckels JAC, Bramhall SR.
Surgical treatment of metastases to the pancreas.
Surgeon 2005;3(2):79-83.
47. Silva MA, Tekin K, Atykin F, Bramhall SR, Buckels JAC, Mirza DF.
Surgery for hilar cholangiocarcinoma; a ten year experience of a tertiary referral centre in the UK.
European Journal of Surgical Oncology 2005;31(5);533-539.
48. Silva MA, Richards DA, Bramhall SR, Adams DH, Mirza DF, Murphy N.
A study of the metabolites of ischaemia-reperfusion injury and selected amino acids in the liver
using microdialysis during transplantation.
Transplantation 2005;79(7):828-835.
49. Jarufe NP, Coldham C, Orug T, Mayer AD, Mirza DF, Buckels JAC, Bramhall SR.
Neuroendocrine tumours of the pancreas: Predictors of survival after surgical treatment.
Digestive Surgery 2005;22(3):157-162.
50. Haydon E, Haydon G, Bramhall S, Mayer AD, Neil D.
Hepatic epithelioid haemangioendothelioma.
Journal of the Royal Society of Medicine 2005;98:364-365.
51. Brammer RD, Bramhall SR, Eggo M.
Endostatin expression in a pancreatic cell line is modulated by a TNFalpha- dependent elastase.
British Journal of Cancer 2005;93(9):1024-1028.
52. Silva MA, Jambulingam PS, Mayer AD, Buckels JAC, Gunson BK, Mirza DF, Bramhall SR.
Hepatic artery thrombosis following orthotopic liver transplantation; a 10 year experience from a
single centre in the UK.
Liver Transplantation 2006;12(1):146-151.
19
53. Kondili LA, Lala A, Gunson BK, Hubscher SG, Olliff S Elias E, Bramhall SR, Mutimer DJ.
Primary hepatocellular cancer in the explanted liver: outcome of transplantation and risk factors
for HCC recurrence.
European Journal of Surgical Oncology 2007;33(7):868-73..
54. Palmer DH, Stocken DD, Hewitt H, Markham CE, Hassan AB, Johnson PJ, Buckels JAC, Bramhall
SR.
A randomised phase II trial of neoadjuvant chemotherapy in resectable pancreatic cancer:
Gemcitabine alone vs. gemcitabine combined with cisplatin.
Annals of Surgical Oncology 2007; 14(7):2088-96.
55. Wojcicki M, Silva MA, Jethwa P, Gunson B, Bramhall SR, Mayer D, Buckels JAC, Mirza DF.
Biliary complications following adult right lobe ex vivo split liver transplantation.
Liver Transplantation 2006;12(5):839-844.
56. Silva MA, Murphy N, Richards DA, Wigmore SJ, Bramhall SR, Buckels JAC, Adams DH, Mirza
DF.
Interstitial lactic acidosis in the graft during organ harvest, cold storage and reperfusion of human
liver allografts predicts subsequent ischemia reperfusion injury.
Transplantation 2006;82(2):227-233.
57. John AR, Haghighi KS, Taniere P, Esmad E, Tan YM, Bramhall SR.
Is a raised CA 19-9 diagnostic for a cholangiocarcinoma in patients with no history of sclerosing
cholangitis.
Digestive Surgery 2006;23:319-324.
58. Höroldt BS, Burattin M, Gunson BK, Bramhall SR, Nightingale P, Hübscher SG, Neuberger JM.
Does the BANFF rejection activity index predict outcome in patients with early acute cellular
rejection following liver transplantation?
Liver Transplantation 2006;12:1144-1151.
59. John AR, Khan S, Mirza DF, Mayer AD, Buckels JAC, Bramhall SR.
Multivariate and univariate analysis of prognostic factors following resection in HCC: The
Birmingham experience.
Digestive Surgery 2006;23:103-109.
60. Jethwa P, Breuning E, Bhati C, Buckels JAC, Mirza DF, Bramhall SR.
The microbiological impact of preoperative biliary drainage on patients undergoing hepato-biliarypancreatic (HPB) surgery.
Alimentary Pharmacology and Therapeutics 2007;25(10):1175-1180.
61. Tamijmarane A, Ahmed I, Bhatti CS, Mirza DF, Mayer AD, Buckels JAC, Bramhall SR.
Role of completion pancreatectomy as a damage control option for post pancreatic surgical
complications.
Digestive Surgery 2006;23(4):229-234.
62. Wojcicki M, Silva MA, Jethwa P, Gunson B, Bramhall SR, Mayer D, Buckels JAC, Mirza DF.
Biliary complications following adult right lobe ex vivo split liver transplantation.
Liver Transplantation 2006;12:839-844.
63. Jethwa P, Sodergen M, Lala A, Weber J, Buckels JA, Bramhall SR, Mirza DF.
Diabetic control after total pancreatectomy
Digestive and Liver Disease 2006;38(6):415-419.
64. Adham M, Mirza DF, Chapius F, Mayer AD, Bramhall SR, Coldham C, Baulieux J, Buckels J.
Results of vascular resections during pancreatectomy from two European centres: an analysis of
survival and disease-free survival explicative factors.
HPB 2006;8:465-473.
20
65. Khan S, Silva MA, Tan YM, John A, Gunson B, Buckels JAC, Mayer AD, Bramhall SR, Mirza
DF.
Conventional versus piggyback technique of caval implantation; without extra-corporeal veno
-venous bypass. A comparative study.
Transplant International 2006;19(10):795-801.
66. Koukoutsis I, Bellagamba R, Morris-Stiff G, Wickremesekera S, Coldham C, Wigmore SJ, Mayer
AD, Mirza DF, Buckels JAC, Bramhall SR.
Haemorrhage following pancreaticoduodenectomy: Risk factors and the importance of sentinel
bleed.
Digestive Surgery 2006;23(4):224-228.
67. Silva MA, Mirza DF, Buckels JAC, Bramhall SR, Mayer AD, Wigmore SJ, Murphy N, Richards
DA.
Arginine and urea metabolism in the liver graft: A study using microdialysis in human orthotopic
Liver transplantation.
Transplantation 2006;82(10):1304-1311.
68. Zang W, Jambulingham PS, Silva M, Taniere P, Mayer D, Bramhall S, Buckels J, Mirza DF.
Orthotopic liver transplantation for epitheliod haemangioendothelioma.
European Journal of Surgical Oncology 2007;33(7):898-901.
69.Koukoutsis I, Bellagamba R, Tamijmarane A, Gunson B, Muralidharan V, Wigmore SJ, Mayer DA,
Mirza DF, Buckels JA, Bramhall SR.
Outcomes after identical and compatible orthotopic liver transplantation for fulminant hepatic
failure: a single centre experience in UK.
Transplant International 2007;20(8):659-65.
70.Koukoutsis I, Tamijmarane A, Bellagamba R, Bramhall S, Buckels J, Mirza D.
The impact of splenectomy on outcomes after distal and total pancreatectomy
World Journal of Surgical Oncology 2007;5:61-65.
71.Alabraba EB, Taniere P, Reynolds GM, Stewart PM, Wigmore SJ, Bramhall SR.
Expression and functional consequences of oestrogen and progesterone receptors in human
insulinomas.
Endocrine-Related Cancer 2007;14:1081-1088.
72. Tamijmarane A, Bhati CS, Mirza DF, Bramhall SR, Mayer DA, Wigmore SJ, Buckels JAC.
Application of Portsmouth Modification of Physiological and Operative Severity Scoring System
for enumeration of morbidity and mortality (P-POSSUM) in pancreatic surgery.
World Journal of Surgical Oncology 2008;6:39.
73. Carter R, Stocken DD, Ghaneh P, Bramhall SR, Olah A, Kelemen D, Bassi C, Friess F, Dervenis C,
Spry C, Büchler MW, Neoptolemos JP.
Longitudinal quality of life data can provide insights on the impact of adjuvant treatment for
pancreatic cancer – subset analysis of the ESPAC-1 data.
International Journal of Cancer 2009;15;124(12):2960-5.
74. Silva MA, Coldham C, Mayer AD, Bramhall SR, Buckels JAC, Mirza DF.
Specialist outreach service for on-table repair of iatrogenic bile duct injuries – a new kind of
‘travelling surgeon’.
Annals of the Royal College of Surgeons of England 2008;90(3):243-246.
75. Stocken DD, Hassan AB, Altman DG, Billingham LJ, Bramhall SR, Johnson PJ, Freemantle N.
Modelling Prognostic Factors in Advanced Pancreatic Cancer.
British Journal of Cancer 2008;99:883-893.
76. John AR, Bramhall SR, Eggo MC.
Antiangiogenic therapy and surgical practice.
British Journal of Surgery 2008;95(3):281-293.
21
77.Morris-Stiff G, Bhati C, Olliff S, Hubscher S, Gunson B, Mayer D, Mirza D, Buckels J, Bramhall
SR.
Cholangiocarcinoma complicating primary sclerosing cholangitis: a 24-year experience.
Digestive Surgery 2008;25(2):126-32.
78.Mehta NN, Ravikumar R, Coldham CA, Buckels JA, Hubscher SG, Bramhall SR, Wigmore SJ,
Mayer AD, Mirza DF.
Effect of preoperative chemotherapy on liver resection for colorectal liver metastases.
European Journal of Surgical Oncology 2007 Jul;34(7):782-6.
79. Marudanayagam R, Shanmugam V, Gunson B, Mirza DF, Mayer AD, Buckels JAC, Bramhall SR.
Aetiology and outcome of acute liver failure.
HPB 2009;11:429-34.
80. Toti L, Attia M, Manzia TM, Lenci I, Gunson B, Buckels JA, Mirza DF, Mayer DA, Bramhall
SR, Wigmore SJ.
Reduction in bile leaks following adult split liver transplant using a fibrin-collagen sponge: a
pilot study.
Digestive and Liver Disease 2010;42(3):205-2009.
81. Marudanayagam R, Krishnamoorthy R, Shanmugam V, Langman G, Rajesh P, Coldham C ,
Bramhall SR, Mayer D, Buckels J, Mirza DF.
Long-term outcome following sequential resections of liver and lung metastases from colorectal
carcinoma.
HPB 2009;11(8):671-6.
82. Morris-Stiff G, Alabraba E, Tan Y-M, Shapey I, Bhati C, Tanniere P, Mayer D, Buckels J,
Bramhall S, Mirza DF.
Assessment of survival advantage in ampullary carcinoma in relation to tumour biology and
morphology
European Journal of Surgical Oncology 2009;35(7):746-50.
83. Bhati CS, Silva MA, Wigmore SJ, Bramhall SR, Mayer DA, Buckels JA, Neil DA, Murphy N,
Mirza DF.
Use of bioelectrical impedance analysis to assess liver steatosis.
Transplant Proceedings 2009;41(5):1677-81.
84. Cherian PT, Chiu K, Gunson B, Bramhall SR, Mayer D, Mirza DF, Buckels JAC.
Pulmonary Thromboembolism in Liver Transplantation. A retrospective review of the first 25
years.
Transplant International 2010;23(11):1113-1119.
85. Ramkumar K, Perera MTPR, Marudanayagam R, Coldham C, Simon P Olliff, Mayer AD,
Bramhall SR, Buckels JAC, Mirza DF.
A re-audit of specialist managed liver trauma following establishment of regional referral and
management guidelines.
The Journal of Trauma, Injury, Infection and Critical Care 2010;68(1):84-89.
86. Houlihan DD, Armstrong MJ, Davidov Y, Hodson J, Nightingale P, Rowe I, Paris S, Gunson B,
Bramhall S, Mutimer D, Neuberger J, Newsome P.
Renal function in patients transplanted for NASH cirrhosis: time to reconsider immunosuppression
regimens?
Liver Transplantation 2011;17(11):1292-1298.
87. Marudanayagam R, Shanmugam V, Sandhu B, Gunson B, Mirza DF, Mayer D, Buckels J,
Bramhall SR.
Liver retransplantation- a single centre 25-year experience.
HPB 2010;12(3):217-224.
22
88. Boot CS, Bramhall SR, Mahon B, Clark PM.
Investigation of the analytical validity of CEA and CA 19-9 measurement in pancreatic cyst fluid
using Roche Elecsys immunoassays.
Clinical Chemistry 2010;56(8):1351-2.
89. Perera MTPR, Monaco A, Silva MA, Bramhall SR, Mayer AD, Buckels JAC, Mirza DF.
Laparoscopic posterior sectoral bile duct injury: Emerging role of conservative management with
improved long term results following delayed diagnosis.
Surgical Endoscopy 2011;25(8):2684-2691.
90. Perera MTPR, Silva MA, Hegab B, Muralidharan V, Bramhall SR, Mayer AD, Buckels JAC,
Mirza DF.
Specialist early and immediate repair of post laparoscopic cholecystectomy (LC) bile duct injuries
(BDI) is associated with an improved long term outcome.
Annals of Surgery 2011;253(3):553-560.
91. Manzia TM, Toti L, Lenci I, Attia M, Tariciotti L, Bramhall SR, Buckels JA, Mirza DF.
Benign disease and unexpected histological findings after pancreaticoduodenectomy: the role of
endoscopic ultrasound fine needle aspiration.
Annals of the Royal College of Surgeons of England 2010; 92(4):295-301.
92. Banz VM, Croagh D, Coldham C, Tanière P, Buckels J, Isaac J, Mayer D, Muiesan P, Bramhall S,
Mirza DF.
Factors influencing outcome in patients undergoing portal vein resection for adenocarcinoma of
the pancreas.
European Journal of Surgical Oncology 2011;38:72-79.
93. Neoptolemos JP, Stocken DD, Bassi C, Ghaneh P, Cunningham D, Goldstein D, Padbury R, Moore
MJ, Gallinger S, Mariette C, Wente MN, Izbicki JR, Friess H, Lerch MM, Dervenis C, Oláh A,
Butturini G, Doi R, Lind PA, Smith D, Valle JW, Palmer DH, Buckels JA, Thompson J, McKay
CJ, Rawcliffe CL, Büchler MW; European Study Group for Pancreatic Cancer. (Bramhall S –
Collaborator)
Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic
cancer resection: a randomized controlled trial.
Journal Of the American Medical Association 2010; 304(10):1073-81.
94. Perera MT, Silva MA, Shah AJ, Hardstaff R, Bramhall SR, Issac J, Buckels JA, Mirza DF.
Risk Factors for Litigation Following Major Transectional Bile Duct Injury Sustained at
Laparoscopic Cholecystectomy.
World Journal of Surgery 2010; 34(11):2635-41.
95. Varma V, Tariciotti L, Coldham C, Taniere P, Buckels JA, Bramhall SR.
Preoperative localisation and Surgical Management of Insulinoma: Single centre experience.
Digestive Surgery 2011;28;63-73.
96. Morris-Stiff G, Tamijmarane A, Tan Y-M, Shapey I, Bhati C, Mayer AD, Buckels JAC,
Bramhall SR, Mirza DF.
Pre-operative stenting is associated with a higher prevalence of post-operative complications
following pancreatoduodenectomy.
International Journal of Surgery 2010;92):145-149.
97. Marudanayagam R, Sandhu B, Perera MTPR, Taniere P, Coldham C, Bramhall S, Mayer D,
Buckels J, Mirza D.
Hepatic resection for non-colorectal, nonneuroendocrine, Non-sarcoma metatsasis – a single centre
Experience.
HPB 2011;13(4);286-292.
98. Dowman JK, Gunson BK, Bramhall S, Badminton MN, Newsome PN.
Liver Transplantation from donors with Acute Intermittent Porphyria.
Annals of Internal Medicine 2011;154(8);571-572.
23
99. Roberts KJ, Bramhall S, Mayer D, Muiesan P.
Uncontrolled organ donation following prehospital cardiac arrest: a potential solution to the
shortage of organ donors in the United Kingdom?
Transplant International 2011;24(5):477-481.
100. Marudanayagam R, Sandhu B, Perera MT, Bramhall SR, Mayer D, Buckels JA, Mirza DF.
Liver resection for metastatic soft tissue sarcoma: an analysis of prognostic factors.
European Journal of Surgical Oncology. 2011;37(1):87-92.
101. Koffman G, Singh I, Bramhall S.
Presumed Consent for Organ Donation
Annals of the Royal College of Surgeons of England 2011;93(4);268-272.
102.Moorlock G, Draper H, Bramhall SR.
Liver transplantation using ‘donation after circulatory death’ donors: the ethics of managing the
end of life care of potential donors to achieve organs suitable for transplantation.
Clnical Ethics 2011:6(3):134-139.
103.Bramhall SR.
How to Address the Gap between Supply and Demand for Cadaveric Organs.
Transplant.med 2011:issue 13.
104.Roberts KJ, Ismail A, Coldham C, Buckels J, Bramhall S.
Long-Term Symptomatic Relief following Surgical Sphincteroplasty for Sphincter of Oddi
Dysfunction.
Digestive Surgery 2011:28;304-308.
105.Aroori S, Puneet P, Bramhall SR, Muiesan P, Mayer AD, Mirza DF, Buckels JC, Isaac J.
Outcomes comparing a pancreaticogastrostomy (PG) and a pancreaticojejunostomy (PJ) after a
pancreaticoduodenectomy (PD).
HPB 2011;13(10);723-731.
106. Dowman JK, Gunson BK, Mirza DF, Bramhall SR, Badminton MN, Newsome PN; on behalf of
the UK Liver Selection and Allocation Working Party.
Liver transplantation for acute intermittent porphyria is complicated by a high rate of
hepatic artery thrombosis.
Liver Transplantation 2011;(in press).
107. Leithead JA, Tariciotti L, Gunson B, Holt A, Isaac J, Mirza DF, Bramhall S, Ferguson JW,
Muiesan P.
Donation after cardiac death liver transplant recipients have an increased frequency of acute
kidney injury.
American Journal of Transplantation 2012;12(4):965-975.
108. Perera MTPR, Bramhall SR.
Current status and recent advances of liver transplantation from donation after cardiac death.
World Journal of Gastrointestinal Surgery 2011;3(11):167-176.
109. Tariciotti L, Rocha C, Perera MT, Gunson BK, Bramhall SR, Isaac J, Buckels JA, Mayer AD,
Muiesan P, Mirza DF.
Is it time to extend liver acceptance criteria for controlled donors after cardiac death?
Transplantation 2011;92(10):1140-1146.
110. Leithead JA, Smith M, Materacki L, Sagar V, Gunson BK, Bramhall SR, Mutimer DJ, Shah T.
Inter-current infection predicts mortality in patients with late hepatic artery thrombosis
listed for liver re-transplantation.
Liver Transplantation 2012;18(11):1353-1360.
24
111. Chamberlain K, Baker MR, Kandaswamy P, Shaw EJ, McVeigh G, Siddiqui F,
Guideline Development Group.
Donor identification and consent for deceased organ donation: summary of NICE guidance.
British Medical Journal 2012;344:341.
112. Roberts KJ, McCulloch N, Sutcliffe R, Isaac J, Muiesan P, Bramhall S, Mirza D, Marudanayagam
R, Mahon BS.
EUS assessment of lesions of the ampulla of Vater: of particular value in low grade dysplasia.
HPB 2013;15(1):18-23.
113. Neoptolemos JP, Moore MJ, Cox TF, Valle JW, Palmer DH, McDonald AC, Carter R, Tebbutt
NC, Dervenis C, Smith D, Glimelius B, Charnley RM, Lacaine F, Scarfe AG, Middleton MR,
Anthoney A, Ghaneh P, Halloran CM, Lerch MM, Oláh A, Rawcliffe CL, Verbeke CS, Campbell
F, Büchler MW; European Study Group for Pancreatic Cancer.
Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation
on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary
cancer randomized trial.
JAMA 2012;308(2):147-156.
114. Battula N, Tsapralis D, Takhar A, Coldham C, Mayer D, Isaac J, Muiesan P, Sutcliffe RP,
Marudanayagam R, Mirza DF, Bramhall SR.
Aetio-pathogenesis and the management of spontaneous liver bleeding in the West: a 16-year
single-centre experience.
HPB 2012;14(6):382-389.
115. Banz VM, Croagh D, Coldham C, Tanière P, Buckels J, Isaac J, Mayer D, Muiesan P, Bramhall
S, Mirza DF.
Factors influencing outcome in patients undergoing portal vein resection for adenocarcinoma of
the pancreas.
European Journal of Surgical Oncology 2012;38(1):72-79.
116. Battula N, Tsapralis D, Mayer D, Isaac J, Muiesan P, Sutcliffe RP, Bramhall S, Mirza D,
Marudanayagam R.
Repeat liver resection for recurrent colorectal metastases: A single centre 13-year experience.
HPB 2013; (in press).
117. Thomas E, Herrington J, Bramhall S, Draper H.
Live liver donation, ethics and practitioners: “I’m between the two and if I don’t feel comfortable
about this situation, I can’t proceed.’’
Journal of Medical Ethics 2013; (in press).
118. Roberts KJ, Hodson J, Mehrzad H, Marudanayagam R, Sutcliffe R, Muiesan P, Isaac J, Bramhall
S, Mirza DF.
A pre-operative predictive score of pancreatic fistula following pancreatoduodenectomy.
HPB 2013; (in press).
119. Roberts KJ, Blanco G, Webber J, Marudanayagam R, Sutcliffe R, Muiesan P, Bramhall SR, Isaac
J, Mirza DF.
Quality of life and diabetic management after total pancreatectomy: a case matched analysis.
HPB 2013; (submitted).
120. Liossis L, Mourad MM, Kumar S, Coldham C, Marudanayagam R, Mirza DF, Isaac J, Muiesan P,
Sutcliffe R, Roberts K, Bramhall SR.
The Liver first approach to synchronous colorectal liver metastasis: outcomes in a tertiary centre.
British Journal of Surgery 2013; (submitted).
121. Rocha C, Perera MTP, Roberts K, Bonney G, Gunson B, Nightingale P, Bramhall SR, Isaac J,
Muiesan P, Mirza DF.
Outcomes following liver transplantation of patients with indo-asian ethnicity.
Liver Transplantation 2013; (submitted).
25
122. Mourad MM, Liossis C, Gunson BK, Mirza DF, Mergental H, Isaac J, Muiesan P, Perera MTPR,
Bramhall SR.
Aetiology and Management of Hepatic Artery Thrombosis after Adult Liver Transplantation.
Liver Transplantation 2013; (submitted).
123. Mourad MM, Algarni A, Gunson BK, Mirza DF, Mergental H, Isaac J, Muiesan P, Perera
MTPR, Bramhall SR.
Tumor characteristics and long-term outcome of incidental hepatocellular carcinoma after
orthotopic liver transplant.
Liver Transplantation 2013; (submitted).
CASE REPORTS & CORRESPONDENCE
1. Winslet MC, Bramhall SR, Neoptolemos JP, Harding LK, Hesslewood SR.
Diffuse increase in renal uptake of technetium 99m methylene diphosphonate in association with
disseminated cholangiocarcinoma.
European Journal of Nuclear Medicine 1990;17:372-73.
2. Bramhall SR, Varma S.
Metastatic squamous cell carcinoma presenting as cellulitis.
British Journal of Plastic Surgery 1991;44:622-23.
3. Bramhall SR, Mangham DC, Keighley MRB.
Endometriosis: A cause of confusion when assessing operative suitability for restorative
proctocolectomy.
Coloproctology 1993;15(1):36-7.
4. Bramhall SR, Winslet MC.
Fatal pulmonary embolus in a keep-fit enthusiast.
British Journal of Hospital Medicine 1993;50(6):342.
5. Kmiot WA, Bramhall SR.
Life quality and psychological morbidity with an ileostomy (letter).
British Journal of Surgery 1993;80(9):1216.
6. Bramhall SR, Neoptolemos JP, Cummins C.
Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of the disease, in
the West Midlands: an epidemiological study (letter).
British Journal of Surgery 1996;83:874.
7. Bramhall SR.
The pre-conceived British beliefs of gastric cancer in Japan need to be changed (letter).
Japanese Journal of Clinical Oncology 1998;28(6):411-412.
8. Slavin J, Bramhall S, Russell RCG, Neoptolemos JP.
Low mortality following resection for pancreatic and periampullary tumours in 1026 patients: UK
survey of specialist pancreatic units (letter).
British Journal of Surgery 1998;85(3):426-427.
9. Bramhall S, Buckels J.
Effect of flutamide on survival in patients with pancreatic cancer (letter).
British Medical Journal 1999;318:326-327.
10.Bramhall SR, Buckels J.
Management of liver trauma (letter).
British Journal of Surgery 2000;87(4):517-518.
26
11.Rezende M, Bramhall SR, Hayes T, Olliff S, Buckels JAC, Candinas D, Mirza DF.
Pancreatic arteriovenous malformation.
Digestive Surgery 2003;20(1):65-69.
12. Messenger D, McAfferty I, Bramhall SR.
Repair of an extensive, dissecting coeliac artery aneurysm by an endovascular approach.
European Journal of Radiology 2006;58:89-92.
13. Bhati CS, Tamijmarane A, Bramhall SR.
A tale of three spilled gallstones: One liver mass and two abscesses.
Digestive Surgery 2006;23:198-200.
14. Buckels JAC, Bramhall SR.
Systematic review of outcome of synchronous portal-superior mesenteric vein resection during
pancreatectomy for cancer.
British Journal of Surgery 2006;93(10):1303.
15. Singhal A, Bramhall SR, Mutimer D.
Abdominal wall burns; a late complication of liver transplant.
Liver Transplantation 2008;14(7):1065-1066.
16. Palmer DH, Stocken DD, Hewitt H, Markham CE, Hassan AB, Johnson PJ, Buckels JAC, Bramhall
SR.
Neoadjuvant Chemotherapy in Resectable Pancreatic Cancer.
Annals of Surgical Oncology 2008 Jul;15(7):2061.
17. Bhatti CS, Bhatt A, Starkey G, Hubscher S, Bramhall S.
Acute liver failure due to primary angiosarcoma : a case report and review of literature.
World Journal of Surgical Oncology 2008;6:104
18. Alabraba EB, Bramhall SR, O’Sullivan B, Mahon B, Taniere P.
Pancreatic insulinoma co-existing with gastric GIST in the absence of neurofibromatosis-1.
World Journal of Surgical Oncology 2009;7:18.
19. Mann CM, Bramhall SR, Buckels JA, Taniere P.
An unusual case of duodenal obstruction-gangliocytic paraganglioma.
Journal of Hepatobiliary Pancreatic Surgery 2009;16(4):562-5.
20. Bhogal RH, Sutaria R, Gunson BK, Bramhall SR.
Similar liver transplantation survival with selected cardiac death donors and brain death donors.
British Journal of Surgery 2010;97(8):1310.
21. Iqbal A, Isaac J, Bramhall S.
Ethical issues and donor numbers.
Anaesthesia 2010;65(6):656.
22. Arulraj R, Bramhall SR, Mahon BS, Boulton R.
Gone and forgotten, a rare complication of peptic ulcer disease.
Endoscopy 2010 (submitted).
23. Tariciotti L, Platto M, Bramhall SR.
A rare cause of massive hepatomegaly.
Liver International 2012;32(7):1112.
24. Tariciotti L, Das I, Perera MTPR, Bramhall SR.
Asymptomatic transmission of Treponema Pallidum (Syphilis) infection through deceased donor
liver transplantation.
Transplant Infectious Diseases 2012;14(3):321-325.
27
25. Gregg, R, Lester, W, Bramhall, S, Wilde, J.
Orthotopic Liver Transplantation in a Patient With Severe Haemophilia A and a High Titre Factor
VIII Inhibitor from an Antithrombin Deficient Cadaveric Donor.
Haemophilia 2013;19(2):e96-7.
26. Scalera I, Kumar S, Bramhall S.
Traumatic Focal Pancreatitis with Retro-Duodenal Hematoma: A Rare Cause of Combined Biliary
and Gastric Outlet Obstruction.
Journal of Pancreas 2012;13(6):690-692.
27. Mourad MM, Liossis C, Kumar S, Bramhall SR.
Primary hepatic tuberculosis in immunocompetent adults – a UK case series.
Journal of Surgical Case Reports 2013; (submitted).
PUBLISHED ABSTRACTS
1. Bramhall SR, Cummins C, Jones AG, Allwood A, Neoptolemos JP.
Incidence, treatment, and survival in 13,560 patients with pancreatic cancer: an epidemiological
study in a UK region (abstract).
GUT 1994;35:A576.
2. Bramhall S, Cummins C, Jones AG, Allwood A, Neoptolemos JP.
Incidence, treatment, and survival in 13,560 patients with pancreatic cancer: an epidemiological
study in a UK region (abstract).
Digestion 1994;55(5):286.
3. Bramhall S, Lemoine N, Stamp G, Donovan I, Dunn J, Neoptolemos J.
72kDa collagenase, stromelysin-1 and tissue inhibitor of metalloproteinase-1 expression in
pancreatic cancer (abstract).
Digestion 1994;55(5):286.
4. Bramhall SR, Lemoine NR, Stamp GWH, Neoptolemos JP.
Enhanced expression of matrix metalloproteinases is often unopposed by their inhibitors (tissue
inhibitors of metalloproteinases) in pancreatic cancer (abstract).
British Journal of Surgery 1995;82(5):707-708.
5. Bramhall SR, Michell NP, Eggo MC, Langman MJS, Neoptolemos JP.
Enhanced mitogenic activity of insulin-like growth factor by insulin-like growth factor binding
proteins in pancreatic cancer cell lines (abstract).
British Journal of Surgery 1995;82(5):705-706.
6. Bramhall SR, Lemoine NR, Stamp GWH, Neoptolemos JP.
MMP upregulation in pancreatic cancer is not countered by an upregulation of TIMPs (abstract).
Digestion 1995;56:275.
7. Bramhall SR, Lemoine NR, Stamp GWH, Neoptolemos JP.
Aggressive MMP upregulation in pancreatic cancer (abstract).
British Journal of Surgery 1995;82(11):1568.
8. Evans JD, Wilson PG, Bramhall SR Neoptolemos JP.
Outcome of surgery for chronic pancreatitis (abstract).
GUT 1996;38:795.
9. Bramhall SR, Lemoine NR, Stamp GWH, Neoptolemos JP.
MMP and MTMMP upregulation is not countered by an upregulation of TIMP2 in pancreatic
cancer (abstract).
GUT 1996;38:797.
28
10.Bramhall SR for the UK Pancreatic Cancer Trials Group.
Adjuvant combined radiotherapy and chemotherapy for pancreatic cancer (abstract).
GUT 1996;38:798.
11.Hastie RH, Baban D, Evans JD, Green NK, Bramhall SR, Neoptolemos JP, Seymour LW.
Expression of vascular endothelial growth factor in pancreatic carcinomas and in the serum of
cancer patients (abstract).
Digestion 1996;57:235.
12.Evans JD, Wilson PG, Carver C, Bramhall SR, Mayer D, McMaster P, Buckels JA,
Neoptolemos JP.
Outcome of surgery for chronic pancreatitis (abstract).
International Journal of Pancreatology 1996;19:218-219.
13.Evans JD, Bramhall SR, Neoptolemos JP, Eggo MC.
Mechanisms of apoptosis in pancreatic cancer cell lines (abstract).
International Journal of Pancreatology 1996;19:218.
14.Evans JD, Bramhall SR, Stark A, Kinley H, Porter C, Osborne L, Daniel F, Carmichael J,
Imrie C, Johnson CD, Neoptolemos JP.
A phase II trial of marimastat (BB-2516) in advanced pancreatic cancer (abstract).
International Journal of Pancreatology 1996;19:218.
15.Baban DF, Hastie RF, Neoptolemos JP, Bramhall SR, Seymour LW.
Expression of vascular endothelial growth factor (VEGF) in pancreatic carcinomas (abstract).
British Journal of Cancer 1996;73(suppl.26):163.
16.Hastie RH, Baban D, Evans JD, Green NK, Bramhall SR, Neoptolemos JP, Seymour LW.
Expression of vascular endothelial growth factor in the primary tumours and sera of patients with
pancreatic cancer (abstract).
British Journal of Surgery 1996;83(11)1632.
17.Evans JD, Bramhall SR, Neoptolemos JP, Eggo MC.
Mechanisms of apoptosis in pancreatic cancer cell lines (abstract).
British Journal of Surgery 1996;83(11):1631.
18.Evans JD, Bramhall SR, Stark A, Kinley H, Porter C, Osborne L, Daniel F, Carmichael J,
Imrie C, Johnson CD, Neoptolemos JP.
A phase II trial of marimastat (BB-2516) in advanced pancreatic cancer (abstract).
British Journal of Surgery 1996;83(11)1652.
19.Evans J, Bramhall S, Carmichael J, Daniel F, Imrie C, Johnson C, Neoptolemos J, Stark A.
A phase II trial of marimastat (BB-2516) in advanced pancreatic cancer (abstract).
Annals of Oncology 1996;7(5):51.
20.Evans JD, Bramhall SR, Donovan IA, Neoptolemos JP, Eggo MC.
Phorbol esters induce apoptosis in pancreatic cancer cell lines (abstract).
GUT 1996;39(3):A251.
21.Bramhall SR, Williams D, Youngs D, Neoptolemos JP.
Type IV collagenase expression is integral to MMP induced in-vitro invasion and is inhibited by
BB2516 and BB94.
GUT 1996;39(3):A257.
22.Bramhall SR, Williams D, Youngs D, Neoptolemos JP.
Type IV collagenase expression is important in MMP induced in-vitro invasion and is inhibited by
BB2516 and BB94.
International Journal of Pancreatology 1997;21:196.
29
23.Evans JD, Bramhall SR, Donovan, IA, Neoptolemos JP, Eggo MC.
Activation of protein kinase C induces apoptosis in SUIT-2 and BxPC3 pancreatic cancer cell
lines.
International Journal of Pancreatology 1997;21:195.
24.Evans JD, Bramhall SR, Stark A, Kinley H, Porter C, Osborne L, Daniel F, Carmichael J,
Imrie C, Johnson CD, Neoptolemos JP.
A phase II trial of marimastat (BB-2516) in advanced pancreatic cancer.
International Journal of Pancreatology 1997;21:191.
25.Evans JD, Wilson PG, Carver C, Bramhall SR, Buckels JAC, Mayer AD, McMaster P,
Neoptolemos JP.
Outcome of surgery for chronic pancreatitis.
British Journal of Surgery 1997;84(1):5.
26.Neoptolemos JP, Bramhall SR, Russell RCG, Johnson CD, Williamson RCN, Benjamin IS,
Alderson D, Kleibeuker JH.
Double-blind, cross-over study comparing the efficacy and tolerance of Creon® 25000 versus
Creon® in patients following total or partial pancreatectomy.
Digestion 1997;58(S2):54.
27.Ghaneh P, Neoptolemos JP, Andrén-Sandberg Å, Bramhall SR, Johnson CD, and members of the
high/low dose pancreatin study.
Steatorrhoea following major pancreatic resection is difficult to control despite the use of high
doses of effective pancreatic enzyme supplements.
International Journal of Pancreatology 1997.
28.Khaliq A, Williams D, Griffin J, Bramhall S, Ahmed A.
Hypoxia down-regulates vascular endothelial growth factor (VEGF) and metalloprotease-2
(MMP-2) in BeWo cells: Implications for impaired invasion in pre-eclampsia.
Placenta, 1997:18(5/6).
29.Gur U, Bramhall S, Dolapci M, Bain I, McMaster P, Mayer D, Buckels JAC.
How and where should blunt liver trauma be managed.
British Journal of Surgery, 1998;85(1):10.
30.Carballo RA, Bastos JLA, Yoong K, Gunson B, Bramhall S, Mayer DAJ, McMaster P,
Buckels JAC.
Hepatic resection for colorectal cancer metastases.
British Journal of Surgery, 1998;85(1):79.
31.Wadley MS, Jones CE, Bramhall SR, Lee MJR, Stonelake PS.
Bone marrow micrometastases and metalloproteinase expression in primary breast cancer.
British Journal of Surgery, 1999:86(1);11.
32.Wadley MS, Jones CE, Bramhall SR, Lee MJR, Stonelake PS.
Detection of bone marrow micrometastases in primary breast cancer: Pre or post operative
sampling.
British Journal of Surgery, 1999:86(1);54.
33.Manu M, Mirza D, Buckels JAC, Bramhall SR.
Expression patterns of neurotrophins and Trk receptors in human pancreatic cancer and their
relationship to perineural invasion.
International Journal of Pancreatology, 2000;27(3):266.
34.Bramhall S, Buckels J, Rosemurgy A, Charnley R, Lloyd D, Steward W, Scarffe H, Johnson C,
Falk S, Rosewicz S, Curtis L and Marimastat Pancreatic Cancer Study Group.
A pivotal randomised controlled study comparing marimastat against gemcitabine as first line
therapy in patients with nonresectable pancreatic cancer.
International Journal of Pancreatology, 2000;27(3):267.
30
35.Brammer RD, Eggo MC, Buckels JAC, Bramhall SR.
The angiogenesis inhibitor endostatin is present in pancreatic tissue and suit-2 cell lines.
International Journal of Pancreatology, 2001;1(2):159.
36.Brammer R, Bramhall SR, Mirza DF, Mayer AD, Candinas D, McMaster P, Buckels
JAC.
Complex liver trauma: A ten-year experience.
British Journal of Surgery 2002;89(S1):60-61.
37.Coldham C, Jarufe N, McMaster P, Mayer AD, Candinas D, Mirza DF, Buckels JAC, Bramhall
SR.
The impact of recent changes in surgical practice on patterns of referral in pancreatic surgery.
Pancreatology, 2002;2(3):325.
38.Brammer RD, Eggo MC, Bramhall SR.
Endostatin production by pancreatic cells is regulated by tumour necrosis factor-alpha and
forskolin.
Pancreatology, 2002;2(3):268-269.
39.Jarufe N, Bramhall SR, Coldham C, Orug T, Rezende M, McMaster P, Mayer AD, Buckels JAC.
A large UK experience in adenocarcinoma of the pancreas and periampullary region.
Pancreatology, 2002;2(3):320.
40.Jarufe N, Bramhall SR, Coldham C, Orug T, Rezende M, McMaster P, Mayer AD, Buckels JAC.
Neuroendocrine tumours of the pancreas and duodenum (NETP).
Pancreatology, 2002;2(3):320.
41. Yoshimura N, Mirza D, Bramhall S, Whiting J.
The usefulness of staging laparoscopy in pancreatic cancer.
British Journal of Surgery, 2003.
42. Imber C, Patel N, Coldham C, Tekin K, Hubscher S, Buckels J, Mayer D, Mirza D, Bramhall S.
Hepatic steatosis/stetohepatitis (NASH) in a cohort of patients undergoing liver resection for
metastatic adenocarcinoma. Does it affect outcome?
British Journal of Surgery, 2003.
43. Silva MA, Mirza DF, Bramhall SR, Mayer AD, McMaster P, Buckels JA.
The treatment of hydatid disease of the liver. Evaluation of an UK experience.
British Journal of Surgery, 2003.
44. Muralidharan V, Silva MA, Bramhall SR, Mayer AD, Buckels JA, Mirza DF.
A UK experience in the management of bile duct injuries following laparoscopic cholecystectomy.
British Journal of Surgery, 2003.
45. Jethwa P, Breuning E, Lala A, Wong T, Bramhall SR, Mirza DF, Mayer AD, Buckels JAC.
Preoperative ERCP drainage of malignant obstructive jaundice: The effect on bile bacteriology.
British Journal of Surgery, 2003.
46. Lala A, Jethwa P, Bramhall SR, Mirza DF, Mayer AD, Buckels JAC.
Role of surgical resection in the management of gastrointestinal stromal tumours (GIST).
British Journal of Surgery, 2003.
47. Tekin K, Shrestha P, Imber C, Atli M, Buckels JAC, Mayer AD, Bramhall SR, Mirza DF.
The surgical management of gallbladder cancer: Results of a tertiary referral centre.
British Journal of Surgery, 2003.
48. Lala A, Jethwa P, Buckels JAC, Mayer AD, Mirza DF, Bramhall SR.
Spontaneous rupture of benign hepatocellular tumours.
British Journal of Surgery, 2003.
31
49. Lala A, Hubscher SG, Yannam GR, Mirza DF, Mayer AD, Buckels JAC, Bramhall S.
Spontaneous rupture of the non-malignant liver: UK perspective.
HPB, 2004 ;6(1) :101.
50. Kato Y, Coldham C, Bramhall SR, Mayer AD, Olliff S, Buckels JAC, Mirza D.
Effect of perioperative blood transfusion on long-term outcome of liver resection for colorectal
metastasis.
British Journal of Surgery, 2005;92(1):3.
51. Jambulingham PS, Silva MA, Kantharia CV, Coldham C, Mayer AD, Buckels JAC, Bramhall SR,
Mirza DF.
Liver resection for non-coloractal non-neuroendocrine hepatic metastases.
British Journal of Surgery, 2005;92(1):74.
52. Silva MA, Muralidhran V, Coldham C, Buckels JAC, Bramhall SR, Mirza DF.
Outcome of on-table repair of iatrogenic bile duct injury: the experience of a tertiary referral unit in
the West Midlands.
British Journal of Surgery, 2005;92(1):116.
53. Breuning E, Jethwa P, Lala A, Buckels JAC, Bramhall SR, Mirza DF.
Should antibiotic prophylaxis be altered after biliary manipulation in HPB patients undergoing
surgery?
British Journal of Surgery, 2006.
54. John AR, Khan S, Mirza DF, Mayer AD, Buckels JAC, Bramhall SR.
Hepatic resection in hepatocellular carcinoma: analysis of 100 cases at a tertiary level centre in the
UK.
British Journal of Surgery, 2006.
55. Alabraba EB, Lai VK, Bramhall SR, Wigmore SJ, Adams DH, Afford SC.
Liver-derived macrophages mediate CD40-dependent cholangiocyte apoptosis and
proinflammatory cytokine release during in vitro co-culture.
Liver Transplantation 2006;12:153.
56. Silva MA, Richards DA, Wigmore SJ, Bramhall SR, Buckels JAC, Adams DH, Mirza DF.
Interstitial lactic acidosis in the graft during organ harvest, cold storage and reperfusion of human
liver allografts predicts subsequent ischaemia reperfusion injury.
Liver Transplantation 2006;12:167.
57. Tamijmarane A, Koukoutsis I, Gunson B, Mayer AD, Mirza DF, Wigmore S, Buckels JAC,
Bramhall SR.
Factors predicting new-onset diabetes mellitus after liver transplantation – a logistic regression
analysis.
Liver Transplantation 2006;12:172.
58. Bhatti CS, Tamijmarane A, Gunson B, Mayer D, Buckels JAC, Mirza DF, Wigmore SJ,
Bramhall SR.
Impact of model for end-stage liver disease (MELD) and delta MELD (DMELD) on outcome
following liver transplantation.
Liver Transplantation 2006;12:317.
59. Bhatti CS, Stiff GM, Gunson B, Mayer D, Buckels JAC, Mirza DF, Wigmore SJ, Bramhall SR.
Prevalence and outcome of cholangiocarcinoma in patients with primary sclerosing cholangitis
referred to a regional liver transplant unit.
Liver Transplantation 2006;12:362.
32
60. Koukoutsis I, Bellagamba R, Muralidharan V, Mayer D, Buckels JA, Mirza DF, Wigmore SJ,
Bramhall SR.
ABO non-identical liver transplantation (LT) for fulminant hepatic failure (FHF).
Liver Transplantation 2006;12:419.
61. Bhatti CS, Silva M, Wigmore S, Bramhall S, Mayer D, Buckels J, Neil D, Murphy N, Mirza D.
Bioelectrical analysis (BIA) – a potential simple tool to assess liver steatosis.
Liver Transplantation 2006;12:420.
62. Adham M, Mirza DF, Chapius F, Mayer AD, Bramhall SR, Coldham C, Baulieux J, Buckels J.
Results of vascular resections during pancreaticoduodenectomy from two European centres: an
analysis of survival and disease free survival explicative factors.
HPB 2006;8:465-473.
63. Morris-Stiff G, Alabraba E, Tan YM, Shapely I, Mayer D, Buckels J, Bramhall S, Mirza D.
Stenting prior to pancreaticoduodenectomy (PD) is associated with increased morbidity and
mortality.
European Journal of Surgical Oncology 2006;32(1) S22.
64. Morris-Stiff G, Tamijmarane A, Tan YM, Shapely I, Bhati C, Mayer D, Buckels J, Bramhall S,
Mirza D.
Survival advantage in ampullary carcinoma: tumour biology or lead-time bias due to tumour
morphology?
European Journal of Surgical Oncology 2006;32(1): S72-S73.
65. Bagia JS, Gunson BK, Mirza DF, Buckels JA, Bramhall SR, Wigmore SJ, Mayer DA.
Splenic artery aneurysm in adult liver transplant.
Liver Transplantation 2007;13(6):S115-116.
66. Cherian PT, Hegab B, Bramhall SR, Mayer D, Mirza DF, Buckels JAC, Wigmore SJ.
The accessory or replaced right hepatic artery. Incidence and consequences of its presence in the
era of multi-organ retrieval.
Liver Transplantation 2008;14(7):S151.
67. Cherian PT, Pissanou T, Tsourouflis G, Boulougouris P, Gunson B, Wigmore SJ, Mirza DF, Mayer
D, Buckels JAC, Bramhall SR.
Vascular complications following adult ex-vivo split liver transplantation – A 10-year experience.
Liver Transplantation 2008;14(7):S165.
68. Cherian PT, Chiu K, Gunson B, Bramhall SR, Mayer D, Mirza DF, Freeman J, Buckels JAC.
Liver transplantation and pulmonary thromboembolism. A retrospective review of 3000
transplants.
Liver Transplantation 2008;14(7):S165.
69. Shanmugam V, Bhatti C, Maruthanayagam R, Buckels J, Mayer D, Mirza D, Gunson G,
Bramhall S.
Retransplantation in fulminant hepatic failure – A single centre experience over 15 years.
Liver Transplantation 2009;15(7):S103.
70. Rocha C, Tariciotti L, Mirza D, Bramhall S, Muiesan P.
Impact of graft steatosis on outcomes of liver transplantation from donors after cardiac death.
Liver Transplantation 2010;16(6):S128.
71. Tariciotti L, Rocha C, Mirza D, Bramhall S, Muiesan P.
DCD liver transplantation: Is it safe with overweight donors?
Liver Transplantation 2010;16(6):S128.
33
72. Aroori S, Sandhu B, Gunson B, Mirza D, Muiesan P, Mayer D, Buckels J, Bramhall S.
Mycophenolate mofetil (MMF) and low dose tacrolimus based immunosuppressive regimen
following orthotopic liver transplantation (OLT): Is it cost effective?
Liver Transplantation 2010;16(6):S132.
73. Tariciotti L, Rocha C, Gunson B, Holt A, Ferguson J, Bramhall S, Muiesan P.
Donation after cardiac death liver transplantation is associated with greater renal dysfunction.
Liver Transplantation 2011;17(6):S109-110.
74. Tariciotti L, Rocha C, Gunson B, Isaac J, Mirza D, Bramhall S, Muiesan P.
Six years of liver transplantation using grafts from controlled donors after cardiac death: A matched
group comparison.
Liver Transplantation 2011;17(6):S121-122.
75. Smith MR, Leithead JA, Materacki LB, Sagar VM, Gunson BK, Bramhall S, Mutimer D, Shah T.
Long-term antibiotic prescription in patients relisted for late hepatic artery thrombosis is associated
with greater wait-list mortality independent of MELD.
Liver Transplantation 2011;17(6):S231.
76. Battula N, Takhar A, Tsapralis D, Mayer D, Isaac J, Muiesan P, Bramhall SR, Sutcliffe RP, Mirza
DF, Marudanayagam R.
Re-do liver resection for recurrent colorectal liver metastasis: A single centre 13 year experience.
HPB 2011;13(3):A084
77. Tsapralis D, Battula N, Takhar A, Mayer D, Isaac J, Muiesan P, Sutcliffe RP, Marudanayagam R,
Mirza DF, Bramhall SR.
Aetio-pathogenesis and management of spontaneous liver bleeding in the West: A 16 year single
centre experience.
HPB 2011;13(3):A136
78. Battula N, Tsapralis D, Croagh D, Takhar A, Mayer D, Isaac J, Muiesan P, Mirza DF, Mahon B,
Bramhall SR.
Role of endoscopic ultrasonography in the diagnosis of cholangiocarcinoma in patients with an
underlying primary sclerosing cholangitis.
HPB 2011;13(3):A171
79. Battula N, Tsapralis D, Mohamedbhai AH, Mayer D, Isaac J, Muiesan P, Mirza DF, Bramhall SR,
Sutcliffe RP, Marudanayagam R, Perera T, Mergental H.
Factors that could predict asystole within an hour after treatment withdrawal in donation after
cardiac death.
HPB 2011;13(3):A219
80. Battula N, Takhar A, Tsapralis D, Mayer D, Isaac J, Muiesan P, Mergental H, Perera MT, Mirza
DF, Bramhall SR.
Risk factor analysis to predict early graft dysfunction following liver transplantation.
HPB 2011;13(3):A276
81. Battula N, Takhar A, Tripathi D, Mergental H, Muiesan P, Isaac J, Mirza D, Mayer D, Bramhall
S, Perera T.
Late graft dysfunction following liver transplantation: Diagnostic dilemma.
Transplant International 2011;24(2):CC008
82. Tariciotti L, Monaco A, Isaac J, Mayer D, Muiesan P, Bramhall S, Perera T, Sutcliffe R, Mirza D.
Treatment of small hepatocellular carcinomas (HCC), liver (LT) transplantation, liver resection
(LR) and radiofrequency ablation (RFA).
Transplant International 2011;24(2):RO261H
83. Takhar AS, Battula N, Neil D, Mergental H, Mirza D, Perera MT, Bramhall SR.
Persistently abnormal liver function in a young patient after liver transplantation: A complex case.
Transplant International 2011;24(2):CC009
34
84. Lordan JT, Gunson B, Mergental H, Isaac J, Mayer D, Muiesan P, Bramhall SR, Mirza DF, Neil
DA, Perera T.
Trends of usage in steatotic liver grafts for orthotopic liver transplantation over a ten year period
in a single institution.
Transplant International 2011;24(2):RO034
85. Perera MTPR, Isaac JR, Bramhall SR, Mayer AD, Mirza DF, Muiesan P.
Adult right lobe live donor liver transplantation (LDLT) in presence of a retro-portal accessory
right hepatic artery (RPARHA) arising from left hepatic artery (LHA).
Transplant International 2011;24(2):LBP0006
BOOK CHAPTERS
1. Neoptolemos JP, Bramhall SR, Lemoine N.
Molecular biology: Diagnostic and prognostic perspectives in pancreatic cancer.
In: Eds. Beger HG, Büchler M. Cancer of the pancreas: Progress in Molecular Biology,
Diagnosis and Treatment. Berlin, Springer-Verlag. 1996;199-211.
2. Neoptolemos JP, Bramhall S, Kerr D.
Principles of adjuvant treatment in pancreatic cancer.
In: Eds. Beger HG, Büchler M. Cancer of the Pancreas: Progress in Molecular Biology,
Diagnosis and Treatment. Berlin, Springer-Verlag. 1996;479-487.
3. Bramhall SR, Dunn JA, Neoptolemos JP.
Epidemiology of pancreatic cancer.
In: Eds. Beger HG, Warshaw AL, Büchler M, Carr-Locke DL, Neoptolemos JP, Russell RCG,
Sarr M. The Pancreas. Boston, Blackwell Scientific. 1998;chapter 96:889-906.
4. Neoptolemos JP, Bramhall SR, Kerr D.
Adjuvant treatment in pancreatic cancer: Combined treatment modalities.
In: Eds. Beger HG, Warshaw AL, Büchler M, Carr-Locke DL, Neoptolemos JP,Russell RCG,
Sarr M. The Pancreas. Boston, Blackwell Scientific. 1998;chapter 119:1104-1119.
5. Bramhall SR, Stamp GWH, Lemoine NR, Neoptolemos JP.
Matrix metalloproteinases and their tissue specific inhibitors in pancreatic cancer.
In: Eds. Neoptolemos JP, Lemoine NR. Pancreatic Cancer: Molecular and Clinical Advances.
Oxford, Blackwell Scientific. 1996;chapter 6:68-91.
6. Bramhall SR, Neoptolemos JP.
Adjuvant treatment of pancreatic cancer.
In: Eds. Neoptolemos JP, Lemoine NR. Pancreatic Cancer: Molecular and Clinical Advances.
Oxford, Blackwell Scientific. 1996;chapter 23:288-307.
7. Bramhall SR, Neoptolemos JP.
Adjuvant treatment of pancreatic cancer.
In: Ed. Dervenis CG. Advances in Pancreatic Disease. Stuttgart, Georg Thieme Verlag. 1996;
339-351.
8. Bramhall SR, Neoptolemos JP.
The role of metalloproteinases and their inhibitors in pancreatic cancer.
In: Ed. Dervenis CG. Advances in Pancreatic Disease. Stuttgart, Georg Thieme Verlag. 1996;
42-55.
9. Evans JD, Bramhall SR, Neoptolemos JP.
Molecular biology and pancreatic disease.
In: Eds. Trede M, Carter DC. Surgery of the Pancreas. London, Churchill Livingstone. 1997.
35
10.Bastos JLA, Bramhall S, McMcaster P.
Treatment of colorectal cancer that has spread to the liver.
In: Eds. McArdle C, Kerr DJ, Boyle P. Colorectal Cancer, Oxford, Isis Medical Media Ltd.
2000;129-144.
11.Bramhall SR.
Lessons learned from the basic science of pancreatic cancer: what the clinician expects from
molecular biology.
In: Eds. Dervenis C, Bassi C. Pancreatic Tumors: Achievements and Prospective. Stuttgart,
Georg Thieme Verlag. 2000;364-386.
12.Bramhall SR.
What happens when things go wrong.
In: Your Body Your Health. London, Carroll and Brown. 2002.
13. Bramhall SR.
The matrix metalloproteinases: Their potential clinical role.
In: Eds. Taylor I, Johnson C. Recent Advances in Surgery. London, RSM Press. 2003;25-41.
14. Perera TP, Bramhall S.
Surgical Aspects of Liver Transplantation.
In: Eds. Neuberger J, Ferguson J, Newsome P. Liver Transplantation.
PRESENTATIONS
1. Bramhall SR, Kmiot WA, Gourevitch D, Wicks AC, Veitch PS.
Endoscopic insertion of an Atkinson tube without X-ray screening: a novel method of oesophageal
intubation.
West Midlands Surgical Society, Stourbridge 1993.
2. Bramhall SR, Durr C, Goldman MD.
Financial pitfalls of a move towards laparoscopic cholecystectomy.
West Midlands Surgical Society, Stourbridge 1993.
3. Stonelake PS, Powell J, Warwick J, Dunn JA, Bramhall SR, Savage A, Neoptolemos JP, Baker PR,
Morrison JM.
Timing of surgery during menstrual cycle for pre-menopausal women with breast cancer.
British Association of Cancer Research, Sheffield 1993.
West Midlands Surgical Society, Stourbridge 1993.
Association of Surgeons, Birmingham 1993. (poster presentation)
4. Bramhall SR, Cummins C, Jones AG, Allwood A, Neoptolemos JP.
Incidence, treatment and survival in 13,560 patients with pancreatic cancer: an epidemiological
study in a UK region.
Pancreatic Society of Great Britain and Ireland, London 1993.
West Midlands Surgical Society, Birmingham 1993.
Midlands Gastroenterological Society, Nottingham 1994. (prize presentation)
European Pancreatic Club, Bologna 1994.
International Association of Pancreatology, Chicago 1994. (poster presentation)
5. Crundwell MC, Bramhall SR, Durr C, Goldman MD.
The evolution of a laparoscopic cholecystectomy service.
West Midlands Surgical Society, Worcester 1994.
6. Williams G, Bramhall SR, Neoptolemos JP.
Purse-string pancreato-jejunostomy following resections for pancreatic disease.
West Midlands Surgical Society, Worcester 1994.
Pancreatic Society of Great Britain and Ireland, Newcastle-Upon-Tyne 1994.
36
7. Bramhall SR, Lemoine NR, Stamp GWH, Donovan IA, Dunn J, Neoptolemos JP.
Collagenase, stromelysin and tissue inhibitor of the metalloproteinase expression in pancreatic and
ampullary cancer.
European Pancreatic Club, Bologna 1994. (poster presentation)
International Association of Pancreatology, Chicago 1994. (Young Investigators Award)
Pancreatic Society of Great Britain and Ireland, Newcastle-Upon-Tyne 1994.
Midlands Gastroenterological Society, Wolverhampton 1994. (poster presentation)
8. Bramhall SR, Friess H, Lemoine NR, Stamp GWH, Büchler M, Beger HS, Neoptolemos JP.
Enhanced expression of matrix metalloproteinases is often unopposed by their inhibitors (tissue
inhibitors of metalloproteinases) in pancreatic cancer.
Surgical Research Society, London 1995.
9. Bramhall SR, Michell NP, Eggo MC, Langman MJS, Neoptolemos JP.
Enhanced mitogenic activity of insulin-like growth factor by insulin-like growth factor binding
proteins in pancreatic cancer cell lines.
Surgical Research Society, London 1995.
10.Wong CH, Gee B, Brown C, Cummins C, Neoptolemos JP, Bramhall SR.
Preoperative prediction of outcome for Kausch-Whipples pancreaticoduodenectomy.
West Midlands Surgical Society, Derby 1995.
11.Michell NP, Bramhall SR, Eggo MC, Neoptolemos JP, Langman MJS.
Autocrine growth stimulation by insulin-like growth factor I is inhibited by binding proteins in
pancreatic cancer.
European Pancreatic Club, Barcelona 1995. (poster presentation)
12.Bramhall SR, Lemoine NR, Stamp GWH, Neoptolemos JP.
MMP upregulation in pancreatic cancer is not countered by an upregulation of TIMPs.
European Pancreatic Club, Barcelona 1995. (poster presentation)
13.Bramhall SR, Lemoine NR, Stamp GWH, Neoptolemos JP.
Aggressive MMP upregulation in pancreatic cancer.
Surgical Research Society, Manchester 1995.
14.Wong CH, Gee B, Brown C, Cummins C, Neoptolemos JP, Bramhall SR.
Outcome following resection for pancreatic ductal adenocarcinoma.
Midlands Gastroenterological Society, Birmingham 1995.
15.Bramhall SR, Buckels J, Neoptolemos JP, UK Pancreatic Cancer Study Group.
Adjuvant combined radiotherapy and chemotherapy for pancreatic cancer.
Midlands Gastroenterological Society, Birmingham 1995.
16.Evans JD, Wilson PG, Bramhall SR, Morton DG, Buckels JAC, Mayer AD, McMaster P,
Neoptolemos JP.
Outcome of surgery for chronic pancreatitis.
West Midlands Surgical Society, Birmingham 1995.
17.Evans JD, Wilson PG, Bramhall SR Neoptolemos JP.
Outcome of surgery for chronic pancreatitis.
Pancreatic Society of Great Britain and Ireland, Birmingham 1995.
18.Bramhall SR, Lemoine NR, Stamp GWH, Neoptolemos JP.
MMP and MTMMP upregulation is not countered by an upregulation of TIMP2 in pancreatic
cancer.
Pancreatic Society of Great Britain and Ireland, Birmingham 1995.
37
19.Bramhall SR for the UK Pancreatic Cancer Trials Group.
Adjuvant combined radiotherapy and chemotherapy for pancreatic cancer.
Pancreatic Society of Great Britain and Ireland, Birmingham 1995.
West Midlands Surgical Society, Birmingham 1995.
20.Baban DF, Hastie RF, Neoptolemos JP, Bramhall SR, Seymour LW.
Expression of vascular endothelial growth factor (VEGF) in pancreatic carcinomas.
British Association of Cancer Research, Edinburgh 1996.
21.Hastie RH, Baban D, Evans JD, Green NK, Bramhall SR, Neoptolemos JP, Seymour LW.
Expression of vascular endothelial growth factor in pancreatic carcinomas and in the serum of
cancer patients.
European Pancreatic Club and International Association of Pancreatology (combined
meeting), Mannheim, Germany 1996.
22.Hastie RH, Baban D, Evans JD, Green NK, Bramhall SR, Neoptolemos JP, Seymour LW.
Expression of vascular endothelial growth factor (VEGF) in the primary tumours and sera of
patients with pancreatic cancer.
Surgical Research Society, Birmingham 1996. (Patey Prize Session)
23.Evans JD, Wilson PG, Carver C, Bramhall SR, Mayer D, McMaster P, Buckels JA,
Neoptolemos JP.
Outcome of surgery for chronic pancreatitis.
European Pancreatic Club and International Association of Pancreatology
(combined meeting), Mannheim, Germany 1996. (poster presentation)
23.Evans JD, Bramhall SR, Neoptolemos JP, Eggo MC.
Mechanisms of apoptosis in pancreatic cancer cell lines.
European Pancreatic Club and International Association of Pancreatology (combined
meeting), Mannheim, Germany 1996. (poster)
Surgical Research Society, Birmingham 1996 (Patey Prize Session).
24.Evans JD, Bramhall SR, Stark A, Kinley H, Porter C, Osborne L, Daniel F, Carmichael J,
Imrie C, Johnson CD, Neoptolemos JP.
A phase II trial of marimastat (BB-2516) in advanced pancreatic cancer.
European Pancreatic Club and International Association of Pancreatology
(combined meeting), Mannheim, Germany 1996. (poster presentation)
25.Evans JD, Bramhall SR, Stark A, Kinley H, Porter C, Osborne L, Daniel F, Carmichael J,
Imrie C, Johnson CD, Neoptolemos JP.
A phase II trial of marimastat (BB-2516) in advanced pancreatic cancer.
Surgical Research Society, Birmingham 1996.
Pancreatic Society of Great Britain and Ireland, London 1996.
26.Bramhall SR, Williams D, Youngs D, Neoptolemos JP.
Type IV collagenase expression is integral to MMP induced in-vitro invasion and is inhibited by
BB2516 and BB94.
United European Gastroenterolgy Week, Paris 1996. (poster presentation)
27.Evans JD, Bramhall SR, Donovan, IA, Neoptolemos JP, Eggo MC.
Phorbol esters induce apoptosis in pancreatic cancer cell lines.
United European Gastroenterolgy Week, Paris 1996. (poster presentation)
28.Evans JD, Bramhall SR, Stark A, Kinley H, Porter C, Osborne L, Daniel F, Carmichael J,
Imrie C, Johnson CD, Neoptolemos JP.
A phase II study of marimastat in advanced pancreatic cancer.
European Society for Medical Oncology, Vienna 1996. (poster presentation)
38
29.Bramhall SR, Williams D, Youngs D, Neoptolemos JP.
Type IV collagenase expression is important in MMP induced in-vitro invasion and is inhibited by
BB2516 and BB94.
Pancreatic Society of Great Britain and Ireland, London 1996.
30.Evans JD, Bramhall SR, Donovan, IA, Neoptolemos JP, Eggo MC.
Activation of protein kinase C induces apoptosis in SUIT-2 and BxPC3 pancreatic cancer cell
lines.
Pancreatic Society of Great Britain and Ireland, London 1996.
31.Bramhall SR, Evans JD, Wilson PG, Carver C, Buckels JAC, Mayer AD, McMaster P,
Neoptolemos JP.
Outcome of surgery for chronic pancreatitis.
Association of Surgeons of Great Britain and Ireland, Bournemouth 1997.
32.Gur U, Dolapci M, Bramhall SR, Jones EL, Buckels JAC.
Pancreatic lymphoma: the importance of accurate histological diagnosis in pancreatic masses.
Midlands Gastroenterological Society, Stafford 1997. (poster presentation)
33.Okajima H, Xu-Min, Bramhall SR, Briton BJ, McGregor-Blair E, Huson S, Maher ER, Heath D,
Buckels JAC.
Pancreas tumours associated with Von-Hippel-Lindau disease.
Midlands Gastroenterological Society, Stafford 1997. (poster presentation)
34.Neoptolemos JP, Bramhall SR, Russell RCG, Johnson CD, Williamson RCN, Benjamin IS,
Alderson D, Kleibeuker JH.
Double-blind, cross-over study comparing the efficacy and tolerance of Creon® 25000 versus
Creon® in patients following total or partial pancreatectomy.
European Pancreatic Club, London 1997. (poster presentation)
35.Ghaneh P, Neoptolemos JP, Andrén-Sandberg Å, Bramhall SR, Johnson CD, and members of the
high/low dose pancreatin study.
Steatorrhoea following major pancreatic resection is difficult to control despite the use of high
doses of effective pancreatic enzyme supplements.
Pancreatic Society of Great Britain and Ireland, Lancaster 1997.
36.Khaliq A, Williams D, Griffin J, Bramhall S, Ahmed A.
Hypoxia down-regulates vascular endothelial growth factor (VEGF) and metalloprotease-2
(MMP-2) in BeWo cells: Implications for impaired invasion in pre-eclampsia.
European Placenta Group, Vigso, Denmark 1997.
37.Olliff JFC, Olliff SP, McCafferty I, Bramhall S, Buckels JAC.
Comparison of dynamic contrast enhanced spiral CT and MRI pre and post Mangafodipir
Trisodium (Tesla scan) in the staging of pancreatic cancer.
Radiology, Birmingham 1998.
38.Gur U, Bramhall S, Dolapci M, Bain I, McMaster P, Mayer D, Buckels JAC.
How and where should blunt liver trauma be managed.
Association of Surgeons of Great Britain and Ireland, Edinburgh 1998.
39.Carballo RA, Bastos JLA, Yoong K, Gunson B, Bramhall S, Mayer DAJ, McMaster P,
Buckels JAC.
Hepatic resection for colorectal cancer metastases.
Association of Surgeons of Great Britain and Ireland, Edinburgh 1998.
40.Bramhall SR, Harrison JD, Burton A, Harrison GR, White A, Wallace DMA, Chan KK, Fielding
JWL.
A phase II trial of radical surgery for locally advanced pelvic neoplasia.
British Association of Surgical Oncology, Liverpool 1998.
West Midlands Surgical Society, Burton 1998.
39
41.Olliff JFC, Olliff SP, McCafferty I, Bramhall S, Buckels JAC.
Comparison of dynamic contrast enhanced spiral CT and MRI pre and post mangafodipir
Trisodium (Tesla scan) in the staging of pancreatic cancer.
European Society of Gastrointestinal and Abdominal Radiology, Marbella 1998.
42.Gur U, Bramhall SR, Afonso R, Dolapci M, Mayer ADM, McMaster P, Buckels JAC.
Is conservative treatment of major blunt liver trauma justified?
International Hepatopancreatobiliary Association, Madrid 1998.
43.Carballo RA, Bastos JLA, Yoong K, Gunson B, Bramhall S, Mayer DAJ, McMaster P,
Buckels JAC.
Hepatic resection for colorectal cancer metastases.
International Hepatopancreatobiliary Association, Madrid 1998.
44.Gur U, Dolapci M, Bramhall SR, Jones EL, Buckels JAC.
Pancreatic lymphoma: the importance of accurate histological diagnosis in pancreatic masses.
International Hepatopancreatobiliary Association, Madrid 1998.
45.Williams DM, Griffin JA, Matthews GM, Buckels JAC, Bramhall SR.
Investigation of the effect of hypoxia on matrix metalloproteinase expression in pancreatic
cancer cell lines.
Pancreatic Society of Great Britain and Ireland, Leeds 1998.
46.Le Cornu K, Gunson BK, Bramhall SR, Mirza DF, Mayer AD, McMaster P, BuckelsJAC.
The evolution of a system specific tumour database.
Pancreatic Society of Great Britain and Ireland, Leeds 1998.
47.Manu M, Bramhall SR, Gur U, Gunson BK, Le Cornu KJ, Mayer AD, Mirza DF, McMaster P,
Buckels JAC.
Improvements in operative mortality for pancreatico-duodenectomy in the West Midlands
following the establishment of a specialist unit.
Pancreatic Society of Great Britain and Ireland, Leeds 1998.
West Midlands Surgical Society, Burton 1998.
48.Gur U, Bramhall S, Afonso R, Dolapci M, Mirza DF, Mayer D, McMaster P, Buckels JAC.
How and where should blunt liver trauma be managed.
West Midlands Surgical Society, Burton 1998.
49.Gur U, Bramhall SR, Afonso RC, Gunson B, Bastos JL, Mayer D, Mirza DF, McMaster P,
Buckels JAC.
Hepatic resection for colorectal cancer metastases.
West Midlands Surgical Society, Burton 1998.
50.Wadley MS, Jones CJ, Bramhall SR, Lee MJR, Stonelake PS.
Bone marrow micrometastases and metalloproteinase expression in primary breast cancer.
Surgical Research Society, Brighton 1999.
51.Wadley MS, Jones CJ, Bramhall SR, Lee MJR, Stonelake PS.
Detection of bone marrow micrometastases in primary breast cancer: Pre or post operative
sampling.
Association of Surgeons of Great Britain and Ireland, Brighton 1999.
52.Manu M, Mirza D, Buckels JAC, Bramhall SR.
Expression patterns of neurotrophins and Trk receptors in human pancreatic cancer and their
relationship to perineural invasion.
Pancreatic Society of Great Britain and Ireland, London 1999.
40
53.Bramhall S, Buckels J, Rosemurgy A, Charnley R, Lloyd D, Steward W, Scarffe H, Johnson C,
Falk S, Rosewicz S, Curtis L & Marimastat Pancreatic Cancer Study Group.
A pivotal randomised controlled study comparing marimastat against gemcitabine as first line
therapy in patients with non-resectable pancreatic cancer.
Pancreatic Society of Great Britain and Ireland, London 1999.
54.Satoi S, Solomon M, Bramhall S, Gunson B, Buckels JAC, Candinas D, Mayer AD, McMaster P,
Mirza DF.
Use of liver grafts from donors with bacterial meningitis.
British Transplantation Society, Cardiff 2000.
55.Whiting J, Bramhall SR, Hallissey MT, Fielding JWL, and Marimastat Gastric Cancer Study
Group.
Marimastat as maintenance therapy for patients with advanced gastric or gastro-oesophageal
cancer: A randomised trial.
The 4th International Gastric Cancer Congress, New York 2001.
56.Brammer RD, Bramhall SR, Eggo MC.
The presence and differential degradation of the angiogenesis inhibitor endostatin in pancreatic
tissue and SUIT-2 cell lines.
Midland Gastroenterological Society, Birmingham 2001.
European Pancreatic Club, Tolouse 2001.
57.Teixeira P, Wilde J, Bramhall SR, Gunson B, Mutimer D, Buckels J, McMaster P, Mirza DF.
Liver transplantation in haemophilia.
European Society of Transplantation, Lisbon 2001.
58.Brammer R, Bramhall SR, Mirza DF, Mayer AD, Candinas D, McMaster P, Buckels
JAC.
Complex liver trauma: A ten-year experience.
Association of Surgeons of Great Britain and Ireland, Dublin 2002.
59.Desai A, Brammer R, Bramhall S, Eggo M.
Endostatin is expressed by oesophageal, gastric and pancreatic cancers and is regulated by
tumour necrosis factor alpha.
American Gastro-enterology Association, San Francisco 2002.
60.Kaukuntla H, Quinn D, Harrington D, Bramhall S, Neil D, Bonser RS.
Metalloproteinases and their inhibitors – the final common pathway for thoracic aortic disease?
Aortic Surgery Symposium VIII, New York 2002.
61.Coldham C, Jarufe N, McMaster P, Mayer AD, Candinas D, Mirza DF, Buckels JAC, Bramhall
SR.
The impact of recent changes in surgical practice on patterns of referral in pancreatic surgery.
European Pancreatic Club and International Association of Pancreatology
(combined meeting), Heidelburg, Germany 2002. (poster presentation, poster prize)
62.Brammer RD, Eggo MC, Bramhall SR.
Endostatin production by pancreatic cells is regulated by tumour necrosis factor-alpha and
forskolin.
European Pancreatic Club and International Association of Pancreatology
(combined meeting), Heidelburg, Germany 2002. (poster presentation)
63.Jarufe N, Bramhall SR, Coldham C, Orug T, Rezende M, McMaster P, Mayer AD, Buckels JAC.
A large UK experience in adenocarcinoma of the pancreas and periampullary region.
European Pancreatic Club and International Association of Pancreatology
(combined meeting), Heidelburg, Germany 2002. (poster presentation)
41
64.Jarufe N, Bramhall SR, Coldham C, Orug T, Rezende M, McMaster P, Mayer AD, Buckels JAC.
Neuroendocrine tumours of the pancreas and duodenum (NETP).
European Pancreatic Club and International Association of Pancreatology
(combined meeting), Heidelburg, Germany 2002. (poster presentation)
65.Jarufe N, Bramhall SR, Coldham C, Orug T, Rezende M, McMaster P, Mayer AD, Buckels JAC.
Neuroendocrine tumours of the pancreas and duodenum.
West Midlands Surgical Society, Birmingham 2002.
66. Coldham C, Jarufe N, McMaster P, Mayer AD, Candinas D, Mirza DF, Buckels JAC,
Bramhall SR.
The impact of recent changes in surgical practice on patterns of referral in pancreatic surgery.
West Midlands Surgical Society, Birmingham 2002.
67. Imber CJ, Tekin K, Atli M, Gunson B, Bramhall SR, Buckels JAC, Mayer AD, McMaster P,
Mirza DF.
Marginal donors – the importance of cold ischaemia time for successful liver transplantation.
British Transplantation Society, London 2003.
68. Imber C, Bramhall S, Buckels J, Mayer D, McMaster P, Mirza D, Mutimer D.
The Birmingham experience of HIV patients undergoing liver transplantation.
British Transplantation Society, London 2003. (poster presentation).
69. Yoshimura N, Mirza D, Bramhall S, Whiting J.
The usefulness of staging laparoscopy in pancreatic cancer.
Association of Surgeons of Great Britain & Ireland, Manchester 2003.
70. Imber C, Patel N, Coldham C, Tekin K, Hubscher S, Buckels J, Mayer D, Mirza D, Bramhall S.
Hepatic steatosis/stetohepatitis (NASH) in a cohort of patients undergoing liver resection for
metastatic adenocarcinoma. Does it affect outcome?
Association of Surgeons of Great Britain & Ireland, Manchester 2003.
71. Silva MA, Mirza DF, Bramhall SR, Mayer AD, McMaster P, Buckels JA.
The treatment of hydatid disease of the liver. Evaluation of an UK experience.
Association of Surgeons of Great Britain & Ireland, Manchester 2003.
72. Muralidharan V, Silva MA, Bramhall SR, Mayer AD, Buckels JA, Mirza DF.
A UK experience in the management of bile duct injuries following laparoscopic cholecystectomy.
Association of Surgeons of Great Britain & Ireland, Manchester 2003.
73. Jethwa P, Breuning E, Lala A, Wong T, Bramhall SR, Mirza DF, Mayer AD, Buckels JAC.
Preoperative ERCP drainage of malignant obstructive jaundice: The effect on bile bacteriology.
Association of Surgeons of Great Britain & Ireland, Manchester 2003.
74. Lala A, Jethwa P, Bramhall SR, Mirza DF, Mayer AD, Buckels JAC.
Role of surgical resection in the management of gastrointestinal stromal tumours (GIST).
Association of Surgeons of Great Britain & Ireland, Manchester 2003. (Poster Presentation).
75. Tekin K, Shrestha P, Imber C, Atli M, Buckels JAC, Mayer AD, Bramhall SR, Mirza DF.
The surgical management of gallbladder cancer: Results of a tertiary referral centre.
Association of Surgeons of Great Britain & Ireland, Manchester 2003. (Poster Presentation).
76. Lala A, Jethwa P, Buckels JAC, Mayer AD, Mirza DF, Bramhall SR.
Spontaneous rupture of benign hepatocellular tumours.
Association of Surgeons of Great Britain & Ireland, Manchester 2003. (Poster Presentation).
77. Jarufe N, Tekin K, Imber C, Gunson B, Bramhall SR, Mayer AD, Buckels JAC, McMaster P,
De Ville de Goyet J, Mirza DF.
A comparison of outcome following whole and right ex-vivo split liver adult transplantation.
European Society for Organ Transplantation. Venice 2003.
42
78. Silva M, Tekin K, Atykin F, Coldham C, Bramhall SR, Mayer AD, Buckels JAC, Mirza DF.
Surgery for hilar cholangiocarcinoma; the importance of liver resection in achieving clear
histological resection margins.
Midland Gastroenterological Society. Wolverhampton 2003.
79. Buckels JAC, Hewitt H, Palmer D, Stocken DD, Markham CE, Johnson PJ, Hassan AB, Bramhall
SR.
A randomised phase II trial of neoadjuvant therapy for patients with resectable pancreatic cancer;
gemcitabine alone vs. gemcitabine combined with cisplatin.
Pancreatic Society of Great Britain and Ireland, Southampton 2003.
80. Yoshimura N, Whiting J, Coldham C, Mirza DF, Bramhall S.
The usefulness of staging laparoscopy in pancreatic cancer.
International Hepato-Pancreato-Biliary Association, Istanbul 2003.
81. Jethwa P, Yoshimura N, Breuning E, Lala A, Wong T, Bramhall SR, Mirza DF, Mayer AD,
Buckels JAC.
Preoperative ERCP drainage of malignant obstructive jaundice: The effect on bile bacteriology.
International Hepato-Pancreato-Biliary Association, Istanbul 2003.
82. Lala AK, Yoshimura N, Jethwa P, Bramhall S, Mirza DF, Mayer AD, Buckels JAC.
Surgical management of GastroIntestinal Stromal Tumours (GIST).
International Hepato-Pancreato-Biliary Association, Istanbul 2003.
83. Muralidharan V, Yoshimura N, Mayer D, Buckels J, McMaster P, Mirza D, Bramhall S.
ABO non-identical liver transplantation (LT) for fulminant hepatic failure (FHF).
International Liver Transplant Society. Kyoto 2004 (Poster Presentation).
84. Muralidharan V, Yoshimura N, Mayer D, Buckels J, McMaster P, Mirza D, Bramhall S.
Impact of acute renal failure (ARF) on outcome after liver transplantation (LT).
International Liver Transplantation Society. Kyoto 2004.
85. Perrin M, Stanton C, Gunson B, Bramhall S.
Improving the educational needs of patients who develop diabetes post liver transplantation through
audit.
British Transplantation Society, Birmingham 2004.
86. Silva MA, Richards DA, Bramhall SR, Adams DH, Mirza DF, Murphy N.
The use of microdialysis for monitoring the metabolic changes that occur in the liver at
transplantation.
British Transplantation Society, Birmingham 2004.
87. Jethwa P, Hayes T, Buckels JAC, Mayer AD, Mirza DF, Bramhall SR.
Biliary complications following right lobe split liver transplantation.
British Transplantation Society, Birmingham 2004 (Poster Presentation).
88. Silva MA, Kahn S, Gunson B, Candinas D, Mayer AD, Buckels JAC, Bramhall SR, Mirza DF.
Liver transplantation without extra-corporeal veno-venous bypass; a comparison of conventional
versus piggyback techniques in adult orthotopic liver transplantation.
British Transplantation Society, Birmingham 2004 (Poster Presentation).
89. Haghighi KS, Orug T, Mirza DF, Stell DA, Mayer AD, Buckels JA, Bramhall SR.
Blood transfusion in organ donors may increase the incidence of acute rejection in liver
Transplantation.
International Society of Transplantation, Vienna 2004 (Poster Presentation).
43
90. Silva MA, Jambulingham P, Muralidharan V, Coldham C, Mayer A, Bramhall S, Mirza D
Outcome of on-table repair of iatrogenic bile duct injury; the experience of a tertiary referral unit in
the West Midlands.
West Midlands Surgical Society, Birmingham 2004.
91. Lala A, Hubscher SG, Yannam GR, Mirza DF, Mayer AD, Buckels JAC, Bramhall S.
Spontaneous rupture of the non-malignant liver: UK perspective.
International Hepato-Pancreato-Biliary Association,Washington 2004.
92. Muralidharan V, Yoshimura N, Mayer D, Buckels J, McMaster P, Mirza D, Bramhall S.
ABO non-identical liver transplantation (LT) for fulminant hepatic failure (FHF).
International Liver Transplant Society, Kyoto 2004.
93. Silva MA, Jambulingam PS, Mayer AD, Buckels JAC, Mirza DF, Bramhall SR.
Hepatic artery thrombosis following Orthotopic liver transplantation; a 10 year experience from the
UK.
British Transplantation Society, Belfast 2005.
94. Silva MA, Wojcicki M, Gunson B, Mayer AD, Buckels JAC, Bramhall SR, Mirza DF.
Biliary complications following adult right lobe split liver transplantation.
British Transplantation Society, Belfast 2005.
95. Kato Y, Coldham C, Bramhall SR, Mayer AD, Olliff S, Buckels JAC, Mirza D.
Effect of perioperative blood transfusion on long-term outcome of liver resection for colorectal
metastasis.
Association of Surgeons of Great Britain & Ireland, Glasgow 2005. (Moynihan Prize Session).
96. Jambulingham PS, Silva MA, Kantharia CV, Coldham C, Mayer AD, Buckels JAC, Bramhall SR,
Mirza DF.
Liver resection for non-colorectal non-neuroendocrine hepatic metastases.
Association of Surgeons of Great Britain & Ireland, Glasgow 2005. (Poster Presentation).
97. Silva MA, Muralidhran V, Coldham C, Buckels JAC, Bramhall SR, Mirza DF.
Outcome of on-table repair of iatrogenic bile duct injury: the experience of a tertiary referral unit in
the West Midlands.
Association of Surgeons of Great Britain & Ireland, Glasgow 2005.
98. Breuning E, Ngogo D, Jethwa P, Bramhall SR, Mirza DF, Buckels JAC.
Pre-operative ERCP drainage of malignant obstructive jaundice: The effect of bile bacteriology.
West Midlands Surgical Society, Dudley 2005.
99. Adham M, Mirza D, Chapuis F, Mayer D, Bramhall S, Baulieux J, Buckels J.
Results of vascular resections during pancreatectomy from two European centres: an analysis of
survival and disease free survival explicative factors.
International Association of Surgeons and Gastroenterologists (and Oncologists), Prague 2005.
100.Adham M, Silva MA, Mirza DF, Chapuis F, Mayer AD, Bramhall SR, Baulieux J, Buckels JAC.
Results of vascular resections during pancreatectomy from two European centres: an analysis of
survival.
Pancreatic Society of Great Britain and Ireland, Birmingham 2005.
101.John AR, Bramhall SR, Eggo MC.
Endostatin – its role in pancreatic cancers.
Pancreatic Society of Great Britain and Ireland, Birmingham 2005.
102.Morris-Stiff G, Wickremseekera K, Silva M, Mayer D, Buckels J, Mirza D, Bramhall S.
Haemorrhage following pancreaticoduodenectomy: a predictable and preventable complication?
Pancreatic Society of Great Britain and Ireland, Birmingham 2005.
44
103.Alabraba EB, Lai VK, Bramhall SR, Adams DH, Afford SC.
Liver macrophages mediate cholangiocyte apoptosis and proinflammatory cytokine release during
co-culture.
Society of Academic and Research Surgery, Edinburgh 2006.
104.Breuning E, Jethwa P, Lala A, Buckels JAC, Bramhall SR, Mirza DF.
Should antibiotic prophylaxis be altered after biliary manipulation in HPB patients undergoing
surgery?
Association of Surgeons of Great Britain & Ireland, Edinburgh 2006.
105.John AR, Khan S, Mirza DF, Mayer AD, Buckels JAC, Bramhall SR.
Hepatic resection in hepatocellular carcinoma: analysis of 100 cases at a tertiary level centre in the
UK.
Association of Surgeons of Great Britain & Ireland, Edinburgh 2006.
106.Alabraba EB, Lai VK, Bramhall SR, Wigmore SJ, Adams DH, Afford SC.
Liver-derived macrophages mediate cd40-dependent cholangiocyte apoptosis and
proinflammatory cytokine release during in vitro co-culture.
International Liver Transplantation Society. Milan 2006.
106.Alabraba EB, Lai VK, Bramhall SR, Wigmore SJ, Adams DH, Afford SC.
Liver macrophages mediate cholangiocyte apoptosis and proinflammatory cytokine release during
co-culture.
British Transplantation Society. Edinburgh 2006.
107.Bhati CS, Morris-Stiff G, Gunson G, Mayer AD, Buckels JAC, Mirza DF, Bramhall SR.
Prevalence and outcome of cholangiocarcinoma in patients with primary sclerosing cholangitis
referred to a regional liver transplant unit.
British Transplantation Society. Edinburgh 2006.
108.Höroldt BS, Burattin M, Gunson BK, Bramhall SR, Nightingale P, Hübscher SG, Neuberger JM.
Does the Banff rejection activity index predict outcome in patients with early acute cellular
rejection following liver transplantation?
European Association for the Study of the Liver. Vienna 2006 (Poster Presentation).
109.Alabraba EB, Lai VK, Bramhall SR, Wigmore SJ, Adams DH, Afford SC.
Liver-derived macrophages mediate CD40-dependent cholangiocyte apoptosis and
proinflammatory cytokine release during in vitro co-culture.
Joint International Congress of ILTS, ELITA & LICAGE. Milan 2006.
110.Silva MA, Richards DA, Wigmore SJ, Bramhall SR, Buckels JAC, Adams DH, Mirza DF.
Interstitial lactic acidosis in the graft during organ harvest, cold storage and reperfusion of human
liver allografts predicts subsequent ischaemia reperfusion injury.
Joint International Congress of ILTS, ELITA & LICAGE. Milan 2006.
111.Tamijmarane A, Koukoutsis I, Gunson B, Mayer AD, Mirza DF, Wigmore S, Buckels JAC,
Bramhall SR.
Factors predicting new-onset diabetes mellitus after liver transplantation – a logistic regression
analysis.
Joint International Congress of ILTS, ELITA & LICAGE. Milan 2006.
112.Bhatti CS, Tamijmarane A, Gunson B, Mayer D, Buckels JAC, Mirza DF, Wigmore SJ,
Bramhall SR.
Impact of model for end-stage liver disease (MELD) and delta MELD (DMELD) on outcome
following liver transplantation.
Joint International Congress of ILTS, ELITA & LICAGE. Milan 2006.
45
113.Bhatti CS, Stiff GM, Gunson B, Mayer D, Buckels JAC, Mirza DF, Wigmore SJ, Bramhall SR.
Prevalence and outcome of cholangiocarcinoma in patienst with primary sclerosing cholangitis
referred to a regional liver transplant unit.
Joint International Congress of ILTS, ELITA & LICAGE. Milan 2006.
114.Koukoutsis I, Bellagamba R, Muralidharan V, Mayer D, Buckels JA, Mirza DF, Wigmore SJ,
Bramhall SR.
ABO non-identical liver transplantation (LT) for fulminant hepatic failure (FHF).
Joint International Congress of ILTS, ELITA & LICAGE. Milan 2006.
115.Bhatti CS, Silva M, Wigmore S, Bramhall S, Mayer D, Buckels J, Neil D, Murphy N, Mirza D.
Bioelectrical analysis (BIA) – a potential simple tool to assess liver steatosis.
Joint International Congress of ILTS, ELITA & LICAGE. Milan 2006.
116.Cherian PT, Mahon BS, Tanierre P, Kejmadi RK, Wigmore SJ, Mirza DF, Mayer D, Buckels JAC,
Bramhall SR.
Impact of endoscopic ultrasound (EUS) on pancreato-biliary practice in a tertiary referral
centre. A new benchmark in diagnostic yield?
West Midlands Surgical Society, Birmingham 2007.
117.Manzia TM, Attia M, Toti L, Gunson B, Mirza DF, Wigmore S, Mayer D, Buckels JAC,
Bramhall S.
An analysis of late mortality after liver transplantation from non transplant related causes.
American Transplant Congress, San Francisco 2007 (Poster Presentation).
118.Bagia JS, Gunson BK, Mayer AD, Mirza DF, Wigmore SJ, Buckels JA, Bramhall SR.
Outcomes and cost implications using marginal donor livers for transplantation in recipients
according to MELD score.
American Transplant Congress, San Francisco 2007.
119.Attia M, Manzia TM, Toti L, Wigmore S, Buckels J, Bramhall S, Mayer D, Mirza DF.
Analysis of 100 cadaveric right lobe split graft. Predictors of poor outcome.
American Transplant Congress, San Francisco 2007 (Poster Presentation).
120.Bagia JS, Gunson BK, Mirza DF, Buckels JA, Bramhall SR, Wigmore SJ, Mayer DA.
Splenic artery aneurysm in adult liver transplant.
ILTS Rio de Janeiro 2007.
121.Toti L, Attia M, Manzia TM, Cherian T, Buckels JAC, Mirza DF, Mayer AD, Wigmore SJ,
Bramhall SR.
Incidental Gallbladder Cancer: Radical Surgery offers Longer Survival
Association of Upper GI Surgeons, Cardiff 2007.
122. Silva MA, Pissanou T, Mehat M, Wigmore SJ, Mayer AD, Bramhall SR, Buckels JAC, Mirza
DF.
Spontaneous haemorrhage of the liver; a management algorithm
Association of Upper GI Surgeons, Cardiff 2007.
123. Cherian PT, Tanierre P, Hejmadi RK, Wigmore SJ, Mirza DF, Mayer D, Bramhall SR, Buckels
JAC, Mahon BS.
Impact of endoscopic ultrasound (EUS) on pancreato-biliary practice in a tertiary referral centre.
A new benchmark in diagnostic yield
Association of Upper GI Surgeons, Cardiff 2007.
124. Manzia TM, Cherian T, Toti L, Wigmore S, Mayer D, Buckels JAC, Bramhall S, Mirza D.
Pancreaticoduodenectomy for benign disease.
Association of Upper GI Surgeons, Cardiff 2007.
46
125. Brooke-Smith M, Tsourouflis G, Solomonov E, Coldham C, Buckels J, Mayer D, Wigmore S,
Bramhall S, Mirza D.
Outcome of and risk factors for dialysis following hepatic resection
Association of Upper GI Surgeons, Cardiff 2007.
126. Cherian PT, Manzia T, Pascoe J, Toti L, Bramhall SR, Wigmore S, Mayer D, Buckels JAC,
Mirza DF.
Primary pancreatic lymphoma: Incidence, histo-pathological characteristics and prognosis derived
from a 10-year experience
Association of Upper GI Surgeons, Cardiff 2007.
127. Cherian PT, Manzia T, Silva M, Toti L, Bramhall SR, Wigmore S, Mayer D, Buckels JAC,
Mirza DF.
Rare primary pancreatic malignancies – presentation and outcome
Association of Upper GI Surgeons, Cardiff 2007.
128. Bhatt AN, Oniscu GC, Gunson B, Coldham C, Mayer AD, Mirza DF, Buckels JAC,
Bramhall SR.
Liver transplantation for polycystic liver disease.
International Hepato-Pancreato Biliary Association, Mumbai 2008.
129. Oniscu GC, Perera T, Gunson B, Buckels JAC, Mirza DF, Bramhall SR, Mayer
AD, Olliff S
Stenting for venous outflow problems post-liver transplantation.
International Hepato-Pancreato Biliary Association, Mumbai 2008.
130. Oniscu GC, Coldham C, Buckels JAC, Mirza DF, Mayer D, Bramhall SR.
The role of open cholecystectomy in the era of laparoscopic surgery.
International Hepato-Pancreato Biliary Association, Mumbai 2008 (poster presentation).
131. Bhatt A, Oniscu GC, Gunson B, Mirza DF, Mayer AD, Buckels JAC, Bramhall
SR.
Transplantation for polycystic liver disease.
International Hepato-Pancreato Biliary Association, Mumbai 2008 (poster presentation).
132. Bhati CS, Gills M, Bramhall SR, Mayer AD, Buckels JAC, Mirza DF.
Clostridium difficile infection in HPB and transplant surgery: increasing concerns?
International Hepato-Pancreato Biliary Association, Mumbai 2008
133. Fazal A, Ahmad N, Ramzan K, Waheed H, Richards S, Bramhall S.
NHS staff and the organ donor register (ODR).
British Transplantation Society, Glasgow 2008.
134. Bhati C, Naidu S, Gunson B, Bramhall S, Buckels J, Mayer D, Mirza D.
Inferior long term graft and patient survival in Asian patients after adult liver transplantation
compared to a matched Caucasian cohort.
British Transplantation Society, Glasgow 2008 (Medawar Medal Session).
135. Perera T, Oniscu G, Gunson B, Buckels J, Mirza DF, Bramhall SR, Mayer D, Olliff S.
The role of vascular stenting in the management of venous complications following orthotopic
liver transplants.
British Transplantation Society, Glasgow 2008 (poster presentation).
136. Cherian PT, Hegab B, Bramhall SR, Mirza DF, Buckels JAC, Mayer D, Wigmore SJ.
The accessory or replaced right hepatic artery. Incidence and consequences of its presence in the
era of multi-organ retrieval.
British Transplantation Society, Glasgow 2008 (poster presentation).
Joint International Congress of ILTS, ELITA & LICAGE, Paris 2008 (poster presentation).
47
137. Cherian PT, Chiu K, Gunson B, Bramhall SR, Mayer D, Mirza DF, Freeman J, Buckels JAC.
Liver transplantation and pulmonary thromboembolism. A retrospective review of 3000
transplants.
British Transplantation Society, Glasgow 2008 (poster presentation).
Joint International Congress of ILTS, ELITA & LICAGE, Paris 2008 (poster presentation).
138. Pissanou T, Tsourouflis G, Boulougouris P, Gunson B, Cherian PT, Wigmore SJ, Mirza DF,
Mayer D, Buckels JAC, Bramhall SR.
Vascular complications following adult ex-vivo split liver transplantation – A 10 year experience.
West Midlands Surgical Society, Shrewsbury 2008.
British Transplantation Society, Glasgow 2008 (poster presentation).
Joint International Congress of ILTS, ELITA & LICAGE, Paris 2008 (poster presentation).
139. Marudanayagam R, Ramkumar K, Shanmugam V, Langmann G, Coldham C, Rajesh P,
Bramhall S, Mayer D, Buckels J, Mirza DF.
Long-term outcome following sequential resections of liver and lung meatastases from colorectal
carcinoma.
Association of Upper GI Surgeons, Liverpool 2008.
140. Ramkumar K, Marudanayagam R, Coldham C, Bramhall SR, Mayer AD, Mirza DF, Buckels
JAC.
Re-audit of liver trauma management and current practice.
Association of Upper GI Surgeons, Liverpool 2008.
141. Cherian PT, Mozdiak E, Karampini E, Coldham C, Bramhall SR, Mirza DF, Buckels J, Mayer D.
Drains and drain fluid analysis post pancreaticoduodenectomy- are we any wiser? a 10-year,
retrospective analysis of over 500 patients
Association of Upper GI Surgeons, Liverpool 2008.
142. Marudanayagam R, Ramkumar K, Shanmugam V, Langmann G, Coldham C, Rajesh P,
Bramhall S, Mayer D, Buckels J, Mirza DF.
Long-term outcome following sequential resections of liver and lung meatastases from colorectal
carcinoma.
American Hepato-Pancreato-Biliary Association, Miami 2009.
143. Marudanayagam R, Shanmugam V, Gunson B, Bramhall S, Mirza DF, Mayer D, Buckels J.
Aetiology and outcome of acute liver failure
American Hepato-Pancreato-Biliary Association, Miami 2009.
144. Shanmugam V, Lala A, Maruthanayagam R, Buckels J, Mirza DF, Mayer D, Bramhall S.
Spontaneous rupture of the non-malignant liver: Our 13 year experience
American Hepato-Pancreato-Biliary Association, Miami 2009.
145. Shanmugam V, Bhatti C, Maruthanayagam R, Buckels J, Mayer D, Mirza D, Gunson G,
Bramhall S.
Retransplantation in fulminant hepatic failure – A single centre experience over 15 years.
International Liver Transplantation Society, New York 2009.
146. Davidov Y, Gunson BK, Saadeddin A, Gopalakrishnan K, Paris S, Mutimer D, Bramhall S,
Hubscher SG, Newsome PN.
Outcome and recurrent disease in patients undergoing liver transplantation for NASH (nonalcoholic steatohepatitis) cirrhosis.
American Association for the Study of Diseases of the Liver, Boston 2009 (presidential Poster
of Distinction).
48
147. Davidov Y, Gunson BK, Saadeddin A, Gopalakrishnan K, Paris S, Mutimer D, Bramhall S,
Hubscher SG, Newsome PN.
Recurrent disease is common in patients undergoing liver transplantation for NASH (nonalcoholic steatohepatitis) cirrhosis, but does not compromise their 5 year outcome.
Midland Gastroenterological Society, Walsall 2009.
148. Gill P, Bramhall S.
Post-procedure antibiotic administration in Hepatopancreaticobiliary patients vs University
Hospital Birmingham antibiotic protocol.
Infection 2009, Birmingham 2009.
149. Marudanayagam R, Sandhu B, Perera MTPR, Taniere P, Coldham C, Bramhall S, Mayer D,
Buckels J, Mirza D.
Outcome following hepatic resection for metastatic malignant mesenchymal tumours.
West Midlands Surgical Society, Birmingham 2009.
150. Marudanayagam R, Sandhu B, Perera MTPR, Taniere P, Coldham C, Bramhall S, Mayer D,
Buckels J, Mirza D.
Hepatic resection for non-colorectal, non-neuroendocrine metastatic tumours- a single centre
Experience.
West Midlands Surgical Society, Birmingham 2009.
151. Rossi R, Buckels J, Mayer D, Mirza D, Isaac J, Muiesan P, Shah T, Taniere P, Bramhall S.
Prognostic factors in resected pancreatic neuroendocrine tumours.
UK and Ireland Neuroendocrine Tumour Society, London 2009.
152. Aroori S, Sandhu B, Gunson B, Jowett S, Isaac J, Muiesan P, Mirza D, Mayer D, Buckels J,
Bramhall SR.
Mycophenolate moeftil (MMF) and low dose Tacrolimus based immunosuppressive regimen
following Orthotopic liver transplantation (OLT): Is it cost-effective?
British Transplantation Society, London 2010
153. Tariciotti L, Rocha C, Perera TM, Bramhall S, Mirza D, Muiesan P.
Is graft steatosis relevant when transplanting NHBD livers?
British Transplantation Society, London 2010
154. Aroori S, Gupta P, Gunson B, Nightingale P, Isaac J, Muiesan P, Mirza D, Mayer D, Buckels J,
Bramhall S.
Comparison of Model for End-Stage liver disease (MELD) & United Kingdom End-Stage Liver
Disease (UKELD) scores as a predictor for death on the liver transplant waiting list and as a
predictor of mortality following liver transplantation.
International Congress of the Transplantation Society, Toronto 2010.
155. Aroori S, Sandhu B, Gunson B, Lowett S, Isaac J, Muiesan P, Mirza D, Mayer D, Buckels J,
Bramhall S.
Cost-effectiveness of Mycophenolate Moefetil and Tacrolimus compared to Azathioprine and
Tacrolimus following Orthotopic liver transplantation (OLT).
International Congress of the Transplantation Society, Toronto 2010.
156. Aroori S, Tariciotti L, Monaco A, Bramhall S.
The safety and outcomes following multi-visceral pancreatic resections.
European Society of Surgical Oncology, Bordeaux 2010.
157. Aroori S,
Pancreatic fistula rate (defined according to the International Study group for Pancreatic Fistula
criteria) and other outcomes between pancreaticogastrostomy (PG) and pancreatico-jejunostomy
(PJ) following pancreaticoduodenenctomy (PD).
European Society of Surgical Oncology, Bordeaux 2010.
49
158. Rocha C, Tariciotti L, Mirza D, Bramhall S, Muiesan P.
Impact of graft steatosis on outcomes of liver transplantation from donors after cardiac death.
International Liver Transplantation Society, Hong Kong 2010.
159. Tariciotti L, Rocha C, Mirza D, Bramhall S, Muiesan P.
DCD liver transplantation: Is it safe with overweight donors?
International Liver Transplantation Society, Hong Kong 2010.
160. Aroori S, Sandhu B, Gunson B, Mirza D, Muiesan P, Mayer D, Buckels J, Bramhall S.
Mycophenolate mofetil (MMF) and low dose tacrolimus based immunosuppressive regimen
following orthotopic liver transplantation (OLT): Is it cost effective?
International Liver Transplantation Society, Hong Kong 2010.
161. Leithead JA, Tariciotti L, Rocha C, Gunson B, Holt A, Ferguson JW, Bramhall S, Muiesan P.
Donation after cardiac death liver transplantation is associated with greater renal dysfunction.
British transplantation Society, Bournemouth 2011.
Joint International Congress of ILTS, ELITA, & LICAGE, Spain 2011.
162. Smith M, Leithead JA, Materacki L, Sagar V, Gunson B, Bramhall S, Mutimer D, Shah T
Long-term antibiotic prescription in patients relisted for late hepatic artery thrombosis is
associated with greater wait-list mortality independent of MELD.
Joint International Congress of ILTS, ELITA, & LICAGE, Spain 2011.
163. Tariciotti L, Rocha C, Gunson B, Isaac J, Mirza D, Bramhall S, Muiesan P.
Six years of liver transplantation using grafts from controlled donors after cardiac death: A
matched group comparison.
Joint International Congress of ILTS, ELITA, & LICAGE, Spain 2011.
164. Smith M, Rye K, Haldane T, Gunson BK, Bramhall SR, Mutimer D
Combined Liver and Kidney Transplantation: a single centre experience.
British Association for the Study of Liver Diseases, London 2011
American Association for the Study of Diseases of the Liver, San Francisco 2011
165. Battula N, Takhar A, Tsapralis D, Mayer D, Isaac J, Muiesan P, Bramhall SR, Sutcliffe RP,
Mirza DF, Marudanayagam R.
Re-do liver resection for recurrent colorectal liver metastasis: A single centre 13 year experience.
Asian-Pacific HPBA, Melbourne 2011
166. Tsapralis D, Battula N, Takhar A, Mayer D, Isaac J, Muiesan P, Sutcliffe RP, Marudanayagam R,
Mirza DF, Bramhall SR.
Aetio-pathogenesis and management of spontaneous liver bleeding in the West: A 16 year single
centre experience.
Asian-Pacific HPBA, Melbourne 2011
167. Battula N, Tsapralis D, Croagh D, Takhar A, Mayer D, Isaac J, Muiesan P, Mirza DF, Mahon B,
Bramhall SR.
Role of endoscopic ultrasonography in the diagnosis of cholangiocarcinoma in patients with an
underlying primary sclerosing cholangitis.
Asian-Pacific HPBA, Melbourne 2011
168. Battula N, Tsapralis D, Mohamedbhai AH, Mayer D, Isaac J, Muiesan P, Mirza DF, Bramhall
SR, Sutcliffe RP, Marudanayagam R, Perera T, Mergental H.
Factors that could predict asystole within an hour after treatment withdrawal in donation after
cardiac death.
Asian-Pacific HPBA, Melbourne 2011
169. Battula N, Takhar A, Tsapralis D, Mayer D, Isaac J, Muiesan P, Mergental H, Perera MT, Mirza
DF, Bramhall SR.
Risk factor analysis to predict early graft dysfunction following liver transplantation.
Asian-Pacific HPBA, Melbourne 2011
50
170. Battula N, Takhar A, Tripathi D, Mergental H, Muiesan P, Isaac J, Mirza D, Mayer D, Bramhall
S, Perera T.
Late graft dysfunction following liver transplantation: Diagnostic dilemma.
European Society for Organ Transplantation, Glasgow 2011
171. Tariciotti L, Monaco A, Isaac J, Mayer D, Muiesan P, Bramhall S, Perera T, Sutcliffe R, Mirza
D.
Treatment of small hepatocellular carcinomas (HCC), liver (LT) transplantation, liver resection
(LR) and radiofrequency ablation (RFA).
European Society for Organ Transplantation, Glasgow 2011
172. Takhar AS, Battula N, Neil D, Mergental H, Mirza D, Perera MT, Bramhall SR.
Persistently abnormal liver function in a young patient after liver transplantation: A complex case.
European Society for Organ Transplantation, Glasgow 2011
173. Lordan JT, Gunson B, Mergental H, Isaac J, Mayer D, Muiesan P, Bramhall SR, Mirza DF, Neil
DA, Perera T.
Trends of usage in steatotic liver grafts for orthotopic liver transplantation over a ten year period
in a single institution.
European Society for Organ Transplantation, Glasgow 2011
174. Perera MTPR, Isaac JR, Bramhall SR, Mayer AD, Mirza DF, Muiesan P.
Adult right lobe live donor liver transplantation (LDLT) in presence of a retro-portal accessory
right hepatic artery (RPARHA) arising from left hepatic artery (LHA).
European Society for Organ Transplantation, Glasgow 2011
175. Neo EL, Vinuela E, Bramhall SR, Isaac J, Marudanayagam R, Mayer D, Mirza DF, Muiesan P,
Sutcliffe RP.
Unplanned hospital readmission within 30 days after liver and pancreatic resection.
Digestive Disease Federation, Liverpool 2012.
176. Viñuela E, Bramhall SR, Isaac J, Marudanayagam R, Mayer D, Mirza DF, Muiesan P, Sutcliffe
RP.
Effect of internal and external pancreatic duct stents on outcome after pancreaticoduodenectomy:
meta-analysis of randomized and observational studies.
Digestive Disease Federation, Liverpool 2012.
177. Roberts K, McCulloch N, Mayer D, Isaac J, Muiesan P, Bramhall S, Mirza D, Sutcliffe R, Forde
C, Marudanayagam R, Mahon B.
EUS assessment of lesions of the ampulla of Vater: of particular value in low grade dysplasia.
Digestive Disease Federation, Liverpool 2012.
178. Neoptolemos JP, Greenhalf W, Cox TF, Campbell F, Palmer DH, Mackey JR, Bassi C, Scarpa A,
Dervenis C, Avgerinos C, Bramhall SR, Valle JW, Corrie P, Middleton MR, Cunningham D,
Friess H, GarnerE, Buchler MW, European Study Group for Pancreatic Cancer.
Evaluation of the chemotherapy response markers hENT1, dck1 and CNT1 in patients with
resected pancreatic ductal adenocarcinoma randomized to observation or adjuvant gemcitabine or
5FU/FA in the ESPAC1/3 trials.
American Society of Clinical Oncology, Chicago 2012.
179. Thomas E, Draper H, Bramhall S.
An Empirically Informed Ethical Analysis of Live Liver Donations.
The Transplantation Society, Berlin 2012.
International association of Bioethics, Rotterdam 2012
180. Mourad M, Kumar S, Liossis C, Gunson BK, Shah T, Olliff S, Mangat K, Bramhall SR, Isaac
J, Mayer D, Perera MTP, Muiesan P, Mirza DF, Mergental H.
Feasibility of ablate and wait strategy with a salvage liver transplant for single hepatocellular
carcinoma lesions less than 3 cm.
EASL HCC Workshop, Istanbul 2013.
51
181. Mihaylov V, Houlihan D, Vinuela E, Gunson BK, Shah T, Bramhall SR, Isaac J, Perera MTP,
Muiesan P, Mirza DF, Mergental H.
Liver transplantation for hepatocellular carcinoma with marginal grafts: intention to treat
outcomes.
EASL HCC Workshop, Istanbul 2013.
182. Mourad M, Liossis C, Kumar S, Gunson BK, Olliff S, Mangat K, Bramhall SR, Isaac J, Perera
MTP, Muiesan P, Shah T, Mergental H, Mirza DF.
Outcomes of primary radiofrequency ablation in single hepatocellular carcinoma lesions.
EASL HCC Workshop, Istanbul 2013.
183. Mourad M, Algarni A, Kumar S, Gunson BK, Bramhall SR, Isaac J, Perera MTP, Muiesan P,
Mirza DF, Shah T, Mergental H.
Diabetus mellitus is an independent risk factor for macrovascular tumor invasion in hepatocellular
carcinoma.
EASL HCC Workshop, Istanbul 2013.
184. Murthy V, Murray D, Hebballi S, Bramhall S, Wilde JT.
Outcome of liver transplantation in patients with hereditary bleeding disorders: A single centre
UK experience.
British Society of Haematologists, Liverpool 2013.
185. Scalera I, Catalano G, Isaac J, Marudanayagam R, Muiesan P, Sutcliffe R, Mirza D, Bramhall S.
Predictors of recurrence after pancreatic resections for neuroendocrine tumors.
E-AHPBA, Belgrade 2013.
186. Faulconer E, Navarro A, Merhzad H, Zia Z, Mirza D, Bramhall S, Isaac J, Muiesan P, Sutcliffe
R, Marudanayagam R.
Adult Choledochal Cyst Excision: A single centre UK experience over 17 years
E-AHPBA, Belgrade 2013.
187.Sandhu B, Isaac J, Bramhall S, Muiesan P, Mirza D, Sutcliffe R, Marudanayagam R.
Clinico-pathological features and outcomes of Solid Pseudopapillary Neoplasms of pancreas - a
single centre Western experience.
E-AHPBA, Belgrade 2013.
188.Roberts K, Hodson J, Marudanayagam R, Sutcliffe R, Muiesan P, Isaac J, Bramhall S, Mirza D.
A pre-operative predictive score of pancreatic fistula following pancreaticoduodenectomy
E-AHPBA, Belgrade 2013.
189.Bonney G, Vinuela E, Thompson C, Mihaylov V, Muiesan P, Bramhall S, Perera T, Mergental H,
Isaac J, Mirza D.
The effect of tumour biology on outcomes following liver resections and transplantation for
hepatocellular carcinoma.
E-AHPBA, Belgrade 2013.
190.Toti L, Scalera I, Manzia TM, Sutcliffe R, Marunadayagam R, Bramhall S, Mayer D, Isaac J,
Mirza D.
Incidental gallbladder cancer: Radical surgery offers longer survival.
E-AHPBA, Belgrade 2013.
191.Bhogal R, Bramhall S, Isaac J, Mararudanayagnam R, Mirza D, Muiesan P, Sutcliffe R.
Multivariate analysis of risk factors for early recurrence after resection of colorectal
liver metastases: potential impact on preoperative staging protocols
E-AHPBA, Belgrade 2013.
52
192.Kumar S, Mourad M, Bramhall S, Isaac J, Marudanayagam R, Mayer D, Mirza D, Muiesan P,
Sutcliffe R.
Clinical utility of drain fluid amylase on the first postoperative day after pancreaticoduodenectomy: a comparison between pancreatico-gastric and pancreatico-jejunal reconstruction.
E-AHPBA, Belgrade 2013.
193.Liossis C, Kumar S, Mourad M, Coldham C, Gunson B, Marudanayagam R, Isaac J, Mirza D,
Muiesan P, Sutcliffe R, Bramhall S.
The Liver first approach to synchronous colorectal liver metastasis: outcomes in a tertiary centre.
E-AHPBA, Belgrade 2013.
194.Rocha C, Bonney G, Vinuela E, Roberts K, Bramhall S, Mirza D, Isaac J, Muiesan P, Sutcliffe R,
Marudanayagam R.
Clinico-pathological factors predicting malignancy in ampullary lesions.
E-AHPBA, Belgrade 2013.
195. Mihaylov V, Houlihan D, Gunson B, Shah T, Bramhall S, Isaac J, Muiesan P, Perera T, Mirza D,
Mergental H.
Liver transplantation for hepatocellular carcinoma with marginal grafts: intention to treat
outcomes.
ILCA, Washington 2013.
196. Houlihan DD, Rowe IA, Mihaylov V, Shetty S, Stangou A, Doolin R, Armstrong MJ,
Bramhall S, Isaac J, Perera T, Muiesan P, Mirza D, Shah T, Mergental H.
Recently proposed AFP model fails to predict poor survival in hcc patients listed for liver
transplantation within the UK criteria.
ILCA, Washington 2013.
197. Rajoriya N, Leithead JA, Gunson BK, Bramhall SR, Mutimer DJ.
Patients with late hepatic artery thrombosis listed for liver re-transplantation are disadvantaged by
the implementation of a national scoring system.
AASLD, Washington 2013.
BASL, London 2013.
198. Rajoriya N, Leithead JA, Lord S, Gunson BK, Bramhall SR, Ferguson JW, Hirschfield GM.
Portal hypertension in patients with polycystic liver disease listed for liver transplantation is not
associated with greater morbidity and mortality.
AASLD, Washington 2013.
BASL, London 2013.
199. Rajoriya N, Leithead JA, Lord S, Gunson BK, Bramhall SR, Hirschfield GM, Ferguson JW.
The impact of a national scoring system on wait-list morbidity and mortality for patients with
polycystic liver disease listed for liver transplantation.
AASLD, Washington 2013.
BASL, London 2013.
200. Mourad M, Algarni A, Gunson BK, Bramhall S, Isaac J, Muiesan P, Perera T, Elsharkawy AM,
Mirza D, Mergental H.
Diabetes mellitus is independent significant factor associated with gross-vascular invasion in HCC
patients undergoing orthotopic liver transplantation.
BASL, London 2013.
201. Algarni A, Mourad M, Gunson BK, Mergental H, Isaac J, Muiesan P, Mirza D, Perera T,
Elsharkawy AM, Bramhall S.
Aetiology and risk factors for early mortality after orthotopic liver transplantation: One
centre experience.
BASL, London 2013.
53
202. Mourad M, Liossis C, Gunson BK, Mirza D, Mergental H, Isaac J, Muiesan P, Perera T,
Elsharkawy AM, Bramhall S.
Aetiology and management of hepatic artery thrombosis after adult liver transplantation.
BASL, London 2013.
203. Mourad M, Algarni A, Gunson BK, Mirza D, Mergental H, Isaac J, Muiesan P, Perera T,
Elsharkawy AM, Bramhall S.
Tumor characteristics and long-term outcome of incidental hepatocellular carcinoma after
orthotopic liver transplant.
BASL, London 2013.
204. Dissanayake R, Mourad M, Gunson BK, Mirza D, Mergental H, Isaac J, Muiesan P,
Perera T, Elsharkawy AM, Bramhall S.
Outcome and risk factors for de novo tumors after orthotopic liver transplantation: One
centre experience.
BASL, London 2013.
205.Sutcliffe RP, Kumar S, Bramhall SR, Isaac J, Marudanayagam R, Mirza DF, Muiesan P,
Roberts K.
Safety and efficacy of a targeted enhanced recovery pathway after pancreatico-duodenectomy.
AUGIS, Gateshead 2013.
206. Gardiner D, Richards S, Bramhall S.
Evaluation into ‘failed’ brainstem death testing in the Midlands.
Intensive Care Society. London 2013
INVITED LECTURES
1. Bramhall SR.
Matrix metalloproteinases and their tissue specific inhibitors in pancreatic cancer.
Pancreatic Cancer: Molecular and Clinical Science, Birmingham 1995.
2. Bramhall SR.
Matrix metalloproteinases and their inhibitors in pancreatic cancer.
European Pancreatic Club and International Association of Pancreatology, (combined
meeting), Mannheim, Germany 1996
3. Bramhall SR.
The matrix metalloproteinases and their inhibitors in pancreatic cancer: from molecular science to
a clinical application.
Eurosurgery Roma ‘96 and Italian Surgical Society, Rome 1996.
4. Bramhall SR.
Matrix metalloproteinases: laboratory findings.
4th Wessex Pancreatic Symposium: New Treatments in Pancreatic Cancer, Southampton
1997.
5. Bramhall SR.
Pancreatic disease both benign and malignant.
46th Intensive Course in Surgery, Birmingham 1997.
6. Bramhall SR.
Pancreatic cancer epidemiology.
The Practical Management of Pancreatic Cancer, Windlesham 1997.
54
7. Bramhall SR.
Advances in Gastroenterology: Hepatobiliary - Extrahepatic
Sands Cox Society, Birmingham 1997.
8. Bramhall SR.
The Calman-Hine Proposals: Implications for the trainee.
West Midlands Surgical Society, Birmingham 1998.
9. Bramhall SR.
Lessons learned from the basic science of pancreatic cancer: what the clinician expects from
molecular biology.
European Digestive Surgery, 3rd International Meeting on Pancreatic Diseases, Athens 1999.
10.Bramhall SR.
Colorectal cancer: screening and genetics, prevention.
Update on Bowel, Birmingham Medical Institute, Birmingham 1999.
11.Bramhall SR.
Acute cholecystitis; role of open surgery.
UEGW Postgraduate Course, G.I. Emergencies – Role of Endoscopic Versus Conventional
Surgery, Brussels 2000.
12. Bramhall SR.
Radiology and Surgery: Dual Approach for a Quality HPB Service.
South West Radiology Association. Torquay 2003.
13. Bramhall SR.
Research and rare cancers.
Rare Cancer Conference. Birmingham 2004.
14. Bramhall SR, Markham C.
Surgery for pancreatic cancer in specialist centres.
2nd Annual National Pancreatic Nurse Specialist Meeting. Birmingham 2004.
15. Bramhall SR.
Surgical Aspects of Liver Transplantation.
MASTIG. Birmingham 2004.
16. Bramhall SR.
Prognostic factors in the surgical treatment of adenocarcinoma of the pancreas.
Pancreatic Disease Symposium, Department of Visceral and Transplantation Surgery
University Berne, Inselspital. Berne 2004.
17. Bramhall SR.
Living Related Liver Transplantation; For and Against.
Carrel Club, Birmingham 2005.
18. Bramhall SR.
Assessment of pancreatic cancer
Hepato-Pancreato-Biliary Masterclass, Manchester 2006.
19. Bramhall SR.
Can we get 300 more livers per year?
British Association for the Study of the Liver, Edinburgh 2008.
20. Bramhall SR.
Required referral versus presumed consent.
International Transplant Nurses Society, London 2008.
55
21. Bramhall SR.
Challenges of providing donor material.
Transfusion Medicine Today, London 2008.
22. Bramhall SR.
How preoperative imaging can affect decision making: the surgeons view.
Pancreas and Biliary Imaging. Royal College of Radiologists, Birmingham 2013.
CONFERENCE ORGANISATION
1. Organising Committee Member.
Pancreatic Cancer: Molecular and Clinical Science, Birmingham, June 1995.
2. Organising Committee Member.
84th Meeting of the Surgical Research Society, Birmingham, June 1996.
3. Bramhall SR, Wilson P, Iqbal T.
Controversial Issues in Gastroenterology, Birmingham, November 1996.
4. Bramhall SR, Wilson P.
Current Perspectives in Gastroenterology, Birmingham, November 1997.
5. Bramhall SR, Wilson P, Dowds A.
Current Perspectives in Gastroenterology, Warwick, November 1998.
6. Bramhall SR, Wilson P.
Current Perspectives in Gastroenterology, Birmingham, March 2000.
7. Bramhall SR, Procurement Coordinator Team.
Non-Heart Beating Donor Study Day, Birmingham, September 2004.
8. Bramhall SR.
Midlands HPB Group, Birmingham, October 2004.
9. Bramhall SR.
Midlands HPB Group, Birmingham, March 2007.
56
REFEREES
57